{"study_id": 10485, "supplement_id": 1032, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the potential therapeutic effect of Cnidium monnieri 50% ethanol extract (CME) on hypertension and its vasorelaxant mechanism.", "results_summary": "CME showed concentration-dependent vasorelaxation in rat aortic rings via an endothelium-independent mechanism, inhibited vascular contraction induced by angiotensin II and CaCl2, and significantly reduced blood pressure in hypertensive rats. The active compounds imperatorin and osthole also demonstrated vasorelaxant effects.", "population_specificity": "Sprague Dawley rats and spontaneously hypertensive rats.", "effective_dosage": "CME (1-30 \u00b5g/mL), imperatorin (3-300 \u00b5M), osthole (1-100 \u00b5M).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:15.654332+00:00"}
{"study_id": 10487, "supplement_id": 1032, "safety_score": "80", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to explore the in vitro pharmacological effects of Cnidium monnieri seed extracts, including antioxidant, cytotoxic, antimicrobial, and spermicidal activities.", "results_summary": "The study found significant antioxidant, cytotoxic, and antimicrobial activities in Cnidium monnieri extracts, along with notable spermicidal effects on human spermatozoa, suggesting potential contraceptive applications.", "population_specificity": "Human spermatozoa (n = 30) and in vitro models (e.g., Salmonella typhi TA98/TA100, RBCs).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:17.681628+00:00"}
{"study_id": 10489, "supplement_id": 1032, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the anti-fungal activity of osthole from Cnidium monnieri against Fusarium oxysporum in potatoes and other plant pathogens.", "results_summary": "Osthole at 5 mg/mL significantly inhibited mycelial growth of F. oxysporum, caused morphological changes, and reduced spore germination by 57.40%. It also inhibited other pathogens but not Alternaria solani and Valsa mali.", "population_specificity": "Potato plants infected with Fusarium oxysporum and other plant pathogens.", "effective_dosage": "5 mg/mL", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:19.426010+00:00"}
{"study_id": 10488, "supplement_id": 1032, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the antifungal effects of aqueous extract of Cnidium monnieri (L.) against Trichophyton rubrum and explore its potential mechanism of action.", "results_summary": "The study found that aqueous extract of Cnidium monnieri (L.) at 128 and 256 \u03bcg/ml inhibited T. rubrum growth, damaged its morphology and internal structure, and downregulated chitin synthase (CHS) expression, suggesting a potential antifungal mechanism.", "population_specificity": "In vitro study on Trichophyton rubrum (fungal pathogen).", "effective_dosage": "128 and 256 \u03bcg/ml (single exposure).", "study_duration": "24 hours.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:19.576648+00:00"}
{"study_id": 10491, "supplement_id": 1032, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to screen crude drugs, including Cnidium monnieri, for their inhibitory potential against URAT1 to discover new treatments for hyperuricemia.", "results_summary": "The study found that Cnidium monnieri extract inhibited urate uptake via URAT1, with osthol identified as the active ingredient. Osthol noncompetitively inhibited URAT1 with an IC50 of 78.8 \u00b5M, and the prenyl group at the 8-position of coumarins was crucial for this inhibition.", "population_specificity": "HEK293/PDZK1 cells transiently transfected with URAT1 (in vitro study).", "effective_dosage": "Not specified (IC50 of osthol was 78.8 \u00b5M).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:21.272552+00:00"}
{"study_id": 10492, "supplement_id": 1032, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to elucidate the mechanism of action of Cnidium monnieri ethanol extract (CME) in inducing cell cycle arrest and apoptosis in hepatocellular carcinoma cells.", "results_summary": "CME suppressed HepG2 cell proliferation, induced G1 phase cell cycle arrest, and increased apoptosis. These effects were mediated via the Akt/GSK-3\u03b2 signaling pathway, independent of p53.", "population_specificity": "HepG2 (wild-type p53) and Hep3B (p53-null) hepatocellular carcinoma cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:21.354725+00:00"}
{"study_id": 10493, "supplement_id": 1032, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to explore osthole's (a component of Cnidium monnieri) anti-nociceptive effect on ERK activation in a rat model of lumbar disc herniation-induced mechanical allodynia.", "results_summary": "Osthole ameliorated hyperalgesia by suppressing ERK activation and inhibiting COX-2 mRNA expression in the spinal dorsal horn, demonstrating analgesic effects in the LDH rat model.", "population_specificity": "Rat model of lumbar disc herniation-induced radicular pain.", "effective_dosage": "Not specified (epidural treatment).", "study_duration": "Effects observed up to 28 days post-intervention.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:23.381422+00:00"}
{"study_id": 10494, "supplement_id": 1032, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Cnidium monnieri fruits (CMF) could act as an immunostimulator against infectious diseases by enhancing immune responses.", "results_summary": "CMF significantly increased nitric oxide (NO) and tumor necrosis factor-\u03b1 (TNF-\u03b1) levels, improved macrophage phagocytosis, and prolonged survival rates in mice infected with E. coli. It also stimulated immune mediators in serum, splenocytes, and peritoneal macrophages.", "population_specificity": "Mice (animal study)", "effective_dosage": "Not specified", "study_duration": "Five consecutive days before infection", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:24.553305+00:00"}
{"study_id": 10495, "supplement_id": 1032, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Cnidium monnieri extract (CME) induces apoptosis in HCT116 colon cancer cells and whether this effect occurs via an AMPK-independent pathway.", "results_summary": "CME induced apoptosis in HCT116 cells by inhibiting p-Akt, regulating Bcl-2, and activating Bax/Bak, without dependence on the AMPK pathway. The study demonstrated CME's potential as an apoptosis-inducing agent in colon cancer cells.", "population_specificity": "HCT116 colon cancer cells (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:26.589353+00:00"}
{"study_id": 10496, "supplement_id": 1032, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of osthole (from Cnidium monnieri) on corticosterone production in mouse Y1 adrenocortical cells and its potential mechanism of action.", "results_summary": "Osthole stimulated corticosterone secretion in a dose- and time-dependent manner, enhanced the effect of dibutyryl-cAMP, and increased the expression of steroidogenic enzymes and transcription factors involved in corticosteroid biosynthesis.", "population_specificity": "Mouse Y1 adrenocortical cells (in vitro study)", "effective_dosage": "Not specified (dose-dependent effects observed)", "study_duration": "Not specified (time-dependent effects observed)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:28.346900+00:00"}
{"study_id": 10498, "supplement_id": 1032, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the inhibitory effect of Cnidium monnieri fruit extracts on pulmonary inflammation induced by cigarette smoke condensate and lipopolysaccharide in mice.", "results_summary": "Cnidium monnieri extract reduced airway hyper-responsiveness, inflammatory cell accumulation, and mediator levels, showing comparable or superior effects to cyclosporin A in mitigating pulmonary inflammation.", "population_specificity": "Mice with induced pulmonary inflammation", "effective_dosage": "50 or 200 mg\u00b7kg(-1), administered orally", "study_duration": "12 days (five administrations)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:29.028501+00:00"}
{"study_id": 10497, "supplement_id": 1032, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to provide a comprehensive analysis of Cnidium monnieri's botany, traditional uses, phytochemistry, pharmacology, toxicity, and contraindications, and to suggest future research directions.", "results_summary": "The study identified 350 compounds in Cnidium monnieri, with coumarins (e.g., osthole) as the main active constituents, demonstrating broad pharmacological effects including antipruritic, anti-allergic, antibacterial, and anti-osteoporotic properties. However, the molecular mechanisms and structure-activity relationships remain unclear, necessitating further research.", "population_specificity": "Not specified (in vitro and in vivo studies referenced).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:29.390686+00:00"}
{"study_id": 10499, "supplement_id": 1032, "safety_score": "60", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the toxicity of CMS-1, a fraction of Cnidium monnieri, in rats and dogs to assess its potential as a treatment for hypertension.", "results_summary": "CMS-1 caused reversible adverse effects in the gastrointestinal, liver, thymus, cardiovascular, and hematological systems, with NOAELs of 100mg/kg/day for rats and 50mg/kg/day for dogs. Most effects were reversible after discontinuation.", "population_specificity": "Sprague-Dawley rats and beagle dogs", "effective_dosage": "Rats (0-900mg/kg/day), dogs (0-450mg/kg/day)", "study_duration": "30 days of administration, followed by a 15-day recovery period", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:30.583491+00:00"}
{"study_id": 10490, "supplement_id": 1032, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the anti-inflammatory potential of osthole (from Cnidium monnieri) in LPS-induced RAW 264.7 cells and DSS-induced ulcerative colitis in mice.", "results_summary": "Osthole inhibited inflammatory mediators (NO, PGE2, TNF-\u03b1, IL-6) in vitro and alleviated UC symptoms in mice by reducing weight loss, colon shortening, and tissue lesions, likely via NF-\u03baB and MAPK/p38 pathway inhibition.", "population_specificity": "LPS-stimulated RAW 264.7 cells and DSS-induced UC in BALB/C mice.", "effective_dosage": "Not specified for osthole in the abstract.", "study_duration": "7 days (DSS administration in mice).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:31.076609+00:00"}
{"study_id": 10500, "supplement_id": 1032, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to identify and evaluate bioactive compounds in Cnidium monnieri fruits for their potential anti-inflammatory effects, particularly in inhibiting superoxide anion generation and elastase release.", "results_summary": "The study isolated three new coumarins and identified 14 known compounds from Cnidium monnieri, several of which showed significant inhibition of superoxide anion generation and elastase release in human neutrophils, suggesting potential anti-inflammatory applications.", "population_specificity": "Human neutrophils (in vitro study)", "effective_dosage": "IC50 values \u22647.31 \u00b5g/mL (superoxide inhibition), \u22647.83 \u00b5g/mL (elastase release)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:33.181168+00:00"}
{"study_id": 10501, "supplement_id": 1032, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to investigate the antitumor effects of osthol, a bioactive compound isolated from Cnidium monnieri, both in vitro and in vivo.", "results_summary": "Osthol inhibited the growth of HeLa cells in a time- and concentration-dependent manner, induced apoptosis, and prolonged survival in P-388 D1 tumor-bearing mice. The compound showed lower cytotoxicity in normal cervical fibroblasts.", "population_specificity": "HeLa cells (in vitro) and P-388 D1 tumor-bearing CDF(1) mice (in vivo).", "effective_dosage": "30 mg/kg once daily for 9 days (in vivo).", "study_duration": "9 days (in vivo).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:33.473063+00:00"}
{"study_id": 10503, "supplement_id": 1032, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine the effects of Cnidium monnieri (osthol and total-coumarins) on pituitary-adrenocortex axis function in Kidney Yang Deficiency rats.", "results_summary": "Cnidium monnieri components (osthol and TCR) increased plasma corticosterone (B) and adrenocorticotropic hormone (ACTH) levels in deficient rats, indicating protective effects on the pituitary-adrenocortex axis, while no significant changes were observed in renin (PRA), angiotensin-II (AT-II), or aldosterone (ALD).", "population_specificity": "Kidney Yang Deficiency rat model induced by hydrocortisone acetate.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:36.917487+00:00"}
{"study_id": 10504, "supplement_id": 1032, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine the effects of Cnidium monnieri's total coumarins, essential oil, and water extracts on plasma prostaglandin and cyclic nucleotide levels in rats with Kidney-Yang insufficiency.", "results_summary": "The study found that total coumarins and water extracts significantly normalized plasma PGE2, PGF2 alpha, and cAMP/cGMP levels in rats with Kidney-Yang insufficiency, while the essential oil showed inconsistent effects. The results suggest coumarins may be the active ingredients for invigorating Kidney and strengthening Yang.", "population_specificity": "Rats with induced Kidney-Yang insufficiency.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:37.859495+00:00"}
{"study_id": 10523, "supplement_id": 1033, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to determine whether cocoa extract supplementation reduces the incidence of mild cognitive impairment (MCI) and all-cause probable dementia.", "results_summary": "The study found no significant reduction in the incidence of MCI or dementia with cocoa extract supplementation over 3 years. Statistical power was low, and no cognitive benefits were observed.", "population_specificity": "2,262 participants in a randomized-controlled clinical trial (COSMOS-Mind).", "effective_dosage": "Not specified in the abstract.", "study_duration": "3 years.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:38.712212+00:00"}
{"study_id": 10521, "supplement_id": 1033, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to determine whether cocoa extract supplementation reduces the risk of fractures in older adults.", "results_summary": "Cocoa extract supplementation was not significantly associated with a lower risk of clinical fractures or nonvertebral fractures compared to placebo. The study found no evidence supporting cocoa extract's efficacy in reducing fracture risk in older individuals.", "population_specificity": "Older adults (12,666 females aged \u226565 years and 8,776 males aged \u226560 years) not selected for pre-existing osteoporosis.", "effective_dosage": "500 mg/d flavanols and 80 mg/d (-)-epicatechin.", "study_duration": "Median 3.6 years (interquartile range 3.2-4.2 years).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:38.850264+00:00"}
{"study_id": 10522, "supplement_id": 1033, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to improve the clarification process of aqueous cocoa extract by optimizing protein precipitation and filtration to enhance flavanol content.", "results_summary": "Lower pH in pre-treatment reduced protein content while maintaining flavanol levels, whereas higher pH reduced flavanols by up to 40%. Larger membrane pores improved polyphenol permeation, while smaller pores limited protein permeation, with optimized pH and pore size balancing protein removal and flavanol retention.", "population_specificity": "Not specified (laboratory study on cocoa extract processing).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:39.385140+00:00"}
{"study_id": 10525, "supplement_id": 1033, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether low-dose cocoa extract supplementation could safely and effectively counteract obesity and type-2 diabetes in a diet-induced obesity model of Wistar rats.", "results_summary": "Cocoa extract supplementation significantly reduced body weight gain, fat accumulation, adipocyte size, and improved metabolic markers such as insulin sensitivity and glucose tolerance without adverse effects at tested doses.", "population_specificity": "Wistar rats with diet-induced obesity.", "effective_dosage": "14 and 140 mg kg-1 day-1.", "study_duration": "10 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:41.943149+00:00"}
{"study_id": 10524, "supplement_id": 1033, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to determine whether daily administration of cocoa extract (containing 500 mg/day flavanols) improved cognition in older adults over a 3-year period.", "results_summary": "Cocoa extract had no significant effect on global cognition, memory, or executive function compared to placebo. The study found no cognitive benefit from cocoa extract supplementation over three years.", "population_specificity": "Older adults (mean age 73 years; 60% women; 89% non-Hispanic White).", "effective_dosage": "500 mg/day flavanols.", "study_duration": "3 years.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:42.883007+00:00"}
{"study_id": 10526, "supplement_id": 1033, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the effects of polyphenol-enriched cocoa extract (PCE) on postischemic cardiac damage in normotensive and hypertensive rats.", "results_summary": "PCE reduced infarct size, preserved glutathione levels, enhanced phosphorylation of Akt/GSK-3\u03b2/eNOS pathways, improved mitochondrial function, and decreased superoxide production, indicating protective effects against postischemic cardiac damage.", "population_specificity": "Normotensive Wistar rats and spontaneously hypertensive rats (SHR).", "effective_dosage": "Not specified", "study_duration": "Treatment administered at reperfusion (60 minutes).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:45.409985+00:00"}
{"study_id": 10527, "supplement_id": 1033, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "To evaluate the postprandial cardiometabolic effects and bioavailability of cocoa extract after acute and 4-week daily consumption in overweight/obese middle-aged subjects.", "results_summary": "Acute cocoa extract consumption initially increased systolic blood pressure (SBP) but after 4 weeks, it led to a greater reduction in postprandial SBP compared to the control group. Cocoa-derived metabolites were detected in the cocoa group, confirming bioavailability.", "population_specificity": "Overweight/obese middle-aged subjects (n=24).", "effective_dosage": "1.4 g cocoa extract (415 mg flavanols) per test meal.", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:46.918503+00:00"}
{"study_id": 10530, "supplement_id": 1033, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential of cocoa extract flavanols in targeting multiple mechanisms to prevent age-related cognitive decline, particularly in Alzheimer's disease.", "results_summary": "The study suggests cocoa extract flavanols may benefit cognitive deterioration and promote healthy brain aging, but highlights the need for better standardization in processing, bioavailability testing, and target engagement studies.", "population_specificity": "Not specified (general focus on age-related cognitive decline and Alzheimer's disease).", "effective_dosage": "Not provided", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:47.312406+00:00"}
{"study_id": 10528, "supplement_id": 1033, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effect of cocoa extract supplementation on psychological status and peripheral dopaminergic activity in overweight or obese middle-aged subjects following an energy-restricted diet.", "results_summary": "Cocoa extract supplementation increased plasma HVA concentrations, which was associated with reduced depressive symptoms, but did not significantly affect anxiety symptoms or other plasma monoamines compared to the control group.", "population_specificity": "Overweight or obese middle-aged men and women (mean age 57 \u00b1 5 years, BMI 30.6 \u00b1 2.3).", "effective_dosage": "1.4 g cocoa extract/day (645 mg total polyphenols/day).", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:47.327393+00:00"}
{"study_id": 10529, "supplement_id": 1033, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to analyze the effect of consuming cocoa extract within an energy-restricted diet on urinary metabolomic changes and assess compliance and bioavailability.", "results_summary": "The study found that cocoa extract consumption led to significant changes in urinary metabolites related to theobromine metabolism, flavonoids, and endogenous metabolism, indicating bioavailability and compliance. The cocoa group showed higher levels of these metabolites compared to the control group.", "population_specificity": "Fifty middle-aged volunteers with an average BMI of 30.6 kg/m\u00b2.", "effective_dosage": "1.4 g of cocoa extract (645 mg polyphenols) per day.", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:47.587035+00:00"}
{"study_id": 10531, "supplement_id": 1033, "safety_score": "85", "efficacy_score": 45, "quality_score": 80, "study_goal": "The researchers aimed to determine whether cocoa extract supplementation in ready-to-eat meals could reduce oxidative stress at the DNA level in overweight/obese subjects.", "results_summary": "The study found no significant changes in DNA oxidative status from cocoa extract supplementation, though a marginal decrease in oxidized bases was attributed to weight loss. Inverse associations between oxidized bases and cocoa-derived metabolites suggest potential protective effects over longer periods or in subjects with higher baseline DNA damage.", "population_specificity": "Overweight/obese adults (average age 57.26 years, BMI 30.59 kg/m\u00b2).", "effective_dosage": "1.4 g/day cocoa extract.", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:50.654181+00:00"}
{"study_id": 10532, "supplement_id": 1033, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the health effects of daily cocoa extract consumption within a hypocaloric diet on oxidative status and vascular markers in middle-aged overweight/obese subjects.", "results_summary": "Cocoa extract supplementation improved oxidative status (reduced oxLDL and MPO levels) and some vascular markers, with more pronounced benefits in men. Both groups showed improvements in anthropometric and biochemical measurements, but the cocoa group had additional oxidative benefits.", "population_specificity": "Middle-aged (57.26 \u00b1 5.24 years) overweight/obese (BMI 30.59 \u00b1 2.33 kg/m\u00b2) male and female volunteers.", "effective_dosage": "1.4 g cocoa extract (645.3 mg polyphenols) daily, incorporated into meals.", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:52.367900+00:00"}
{"study_id": 10502, "supplement_id": 1032, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to develop a high-speed counter-current chromatography method for separating and purifying five bioactive coumarins from Cnidium monnieri.", "results_summary": "The study successfully isolated five coumarins with purities of 90.6-98.9% and recoveries of 85.7-94.2% from the crude extract. The method demonstrated efficient separation and purification of bioactive compounds.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:53.831681+00:00"}
{"study_id": 10534, "supplement_id": 1033, "safety_score": "80", "efficacy_score": 90, "quality_score": 85, "study_goal": "The researchers aimed to determine whether cocoa flavonoid extract protects against early alcohol-induced liver injury in rats.", "results_summary": "Cocoa extract significantly blunted ethanol-induced liver damage, including fat accumulation, inflammation, necrosis, and oxidative stress markers, while also normalizing serum alanine aminotransferase levels.", "population_specificity": "Male Wistar rats fed high-fat liquid diets with or without ethanol.", "effective_dosage": "400 mg/kg per day", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:54.226866+00:00"}
{"study_id": 10533, "supplement_id": 1033, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the molecular effects of cocoa flavonoids, specifically a polyphenolic cocoa extract (PCE), on breast cancer cells, focusing on gene expression and potential synergy with tamoxifen.", "results_summary": "PCE incubation altered gene expression in breast cancer cell lines, notably inducing CYP1A1 through AhR activation. PCE combined with tamoxifen showed synergistic cytotoxicity, enhancing apoptosis in MCF-7 cells.", "population_specificity": "MCF-7 and SKBR3 breast cancer cell lines", "effective_dosage": "Not specified", "study_duration": "24 hours", "interactions": "Synergistic effect with tamoxifen", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:55.216236+00:00"}
{"study_id": 185410, "supplement_id": 1033, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to test the effects of cocoa extract (500 mg flavanols/d) and/or a daily multivitamin-mineral (MVM) supplement on cognitive change in older adults, as part of a broader study on cardiovascular disease and cancer prevention.", "results_summary": "The abstract does not report specific results for cocoa extract's effects on cognitive outcomes, focusing instead on the benefits of MVM supplementation.", "population_specificity": "United States adults aged \u226560 years (n = 21,442 total; n = 573 in COSMOS-Clinic substudy).", "effective_dosage": "500 mg flavanols/day (cocoa extract).", "study_duration": "2 years.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:56.546070+00:00"}
{"study_id": 185411, "supplement_id": 1033, "safety_score": "85", "efficacy_score": 30, "quality_score": 90, "study_goal": "The researchers aimed to determine whether daily supplementation with cocoa extract (500 mg flavanols/d) improves cognitive function over 2 years in older adults compared to placebo.", "results_summary": "The study found no significant overall cognitive benefits from cocoa extract supplementation compared to placebo in global cognition, episodic memory, or executive function/attention. Subgroup analysis suggested potential cognitive benefits in individuals with poorer baseline diet quality, but these findings were uncorrected for multiple testing.", "population_specificity": "573 older adults (mean age 69.6 years, 49.2% female) from the COSMOS-Clinic subcohort in the United States.", "effective_dosage": "500 mg flavanols/day, including 80 mg (-)-epicatechin.", "study_duration": "2 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:57.300062+00:00"}
{"study_id": 185412, "supplement_id": 1033, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to evaluate whether cocoa extract supplementation could reduce the risk of incident type 2 diabetes (T2D) in middle-aged and older adults.", "results_summary": "The study found that cocoa extract supplementation (500 mg/day) did not reduce the risk of T2D compared to placebo, with no significant effect observed across various subgroups. The adjusted hazard ratio was 1.04 (95% CI 0.91-1.20, P = 0.58).", "population_specificity": "18,381 U.S. adults (12,666 women aged \u226565 years and 8,776 men aged \u226560 years) without diabetes at enrollment.", "effective_dosage": "500 mg/day cocoa flavanols, including 80 mg (-)-epicatechin.", "study_duration": "Median follow-up of 3.5 years.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:57.798157+00:00"}
{"study_id": 9968, "supplement_id": 1034, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to analyze the chemical composition of Simplah (SM) and pliek (PL) oils derived from fermented coconut meat and evaluate their potential as anti-inflammatory and immunosuppressive agents for atopic dermatitis (AD).", "results_summary": "The study identified 53 compounds in SM and PL oils, with PN32 showing high binding affinity to proteins linked to AD inflammation. PN32 exhibited significant inhibitory activity against JNK1 but lower stability than the control ligand, suggesting potential topical anti-inflammatory and immunosuppressive effects.", "population_specificity": "Not specified (in vitro and molecular docking study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:25:58.999185+00:00"}
{"study_id": 9969, "supplement_id": 1034, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effect of coconut oil on the oral bacteriome and inflammatory response in patients with periodontitis, assessing its potential as a natural adjunct to standard periodontal therapy.", "results_summary": "Coconut oil significantly reduced pathogenic bacteria (e.g., Spirochaetaceae, Tannerellaceae) and increased beneficial bacteria (e.g., Streptococcaceae), while also lowering inflammatory markers (IL-6, TNF-\u03b1), indicating improved periodontal health.", "population_specificity": "30 participants diagnosed with periodontitis.", "effective_dosage": "Not specified", "study_duration": "One month of treatment, with follow-up one month post-non-surgical therapy.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:00.674824+00:00"}
{"study_id": 9971, "supplement_id": 1034, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy of virgin coconut oil (VCO) pulling in reducing microbial load and inflammatory mediators in chronic periodontitis compared to chlorhexidine mouthwash and distilled water.", "results_summary": "VCO pulling significantly reduced viral and bacterial loads and inflammatory mediators, with efficacy comparable to chlorhexidine mouthwash, and both outperformed distilled water.", "population_specificity": "Thirty patients diagnosed with chronic periodontitis.", "effective_dosage": "Not specified (oil pulling frequency not detailed).", "study_duration": "Four weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:02.287017+00:00"}
{"study_id": 9970, "supplement_id": 1034, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to determine whether effleurage massage with coconut oil could reduce leg pain in chronic renal failure patients undergoing hemodialysis.", "results_summary": "The study found that after a month of intervention, 36% of patients reported no pain, 42% had mild pain, and 22% had moderate pain, compared to baseline levels of 70% moderate and 30% mild pain.", "population_specificity": "150 individuals with mild to moderate leg discomfort, aged 30-70, undergoing hemodialysis for chronic renal failure.", "effective_dosage": "Not specified", "study_duration": "1 month", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:02.480004+00:00"}
{"study_id": 9972, "supplement_id": 1034, "safety_score": "30", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of prolonged coconut oil ingestion on adrenal gland morphology and functionality in Mongolian gerbils.", "results_summary": "Prolonged coconut oil consumption increased cell area and thickness of the zona reticularis, caused lipid droplet accumulation, reduced steroidogenic enzyme levels, and increased estrogen receptor alpha expression, suggesting adrenal gland dysfunction.", "population_specificity": "Male Mongolian gerbils, 3 months of age.", "effective_dosage": "0.1 ml of coconut oil daily.", "study_duration": "12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:04.532960+00:00"}
{"study_id": 9975, "supplement_id": 1034, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effects of coconut oil and its bioactive metabolites on cognitive function and Alzheimer's disease progression.", "results_summary": "The meta-analysis found that coconut oil improved cognitive scores in Alzheimer's patients compared to controls, with consistent results across studies. The findings suggest medium-chain triglycerides in coconut oil may enhance cognitive abilities and potentially slow Alzheimer's progression.", "population_specificity": "Patients with Alzheimer's disease", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:04.587832+00:00"}
{"study_id": 9974, "supplement_id": 1034, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effect of coconut oil intake on prostate health in aging gerbils, specifically its potential to mitigate age-related changes and benign prostatic hyperplasia (BPH).", "results_summary": "Coconut oil intake reduced prostate weight, muscle stroma thickness, AR and ER\u03b1 expression, BPH incidence, and intraepithelial neoplasms while increasing apoptosis in prostatic cells, suggesting protective effects against age-related prostate changes.", "population_specificity": "Aging gerbils (Meriones unguiculatus)", "effective_dosage": "Not specified", "study_duration": "1 year", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:04.934212+00:00"}
{"study_id": 9977, "supplement_id": 1034, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether nanoparticle formulations of glutathione (GSH) and virgin coconut oil (VCO) could improve therapeutic outcomes in a rat model of acute liver failure (ALF).", "results_summary": "The nanoparticle mixture of GSH and VCO significantly improved liver function, reduced oxidative stress and inflammatory markers, and decreased hepatocellular necrosis and inflammation in ALF-induced rats.", "population_specificity": "Adult male Albino rats with induced acute liver failure.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Seven days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:06.899580+00:00"}
{"study_id": 9976, "supplement_id": 1034, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of coconut oil (specifically medium-chain triglycerides [MCTs]) on obesity, behavioral changes, and inflammatory markers in rats with depression when consumed with either a standard or high-fat diet.", "results_summary": "The study found that the SD+MCT group showed the least weight gain, spent the most time in the center during behavioral tests, and had the lowest immobilization time, indicating positive behavioral responses. MCTs from coconut oil demonstrated weight-reducing effects and improved behavioral outcomes in depression-related tests.", "population_specificity": "Male Sprague-Dawley rats with induced depression.", "effective_dosage": "5% MCT (from coconut oil) in the diet.", "study_duration": "60 days of dietary intervention.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:07.351721+00:00"}
{"study_id": 9978, "supplement_id": 1034, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether incorporating virgin coconut oil (CCO) into nanostructured lipid carriers (NLC) could enhance the hypolipidemic effects of Rosuvastatin (RSV) in treating dyslipidemia.", "results_summary": "The optimized NLC formulation with CCO showed prolonged in vitro release (93.7% over 24 hours) and significantly enhanced the reduction of total cholesterol levels in obese rat models, suggesting a potential synergistic effect between RSV and CCO. The formulation was stable for 3 months under different storage conditions.", "population_specificity": "Obese rat models", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:09.632751+00:00"}
{"study_id": 9979, "supplement_id": 1034, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether virgin coconut oil (VCO) could mitigate biochemical and behavioral changes in rats exposed to chronic, unpredictable stress.", "results_summary": "VCO demonstrated protective effects against stress-induced alterations in biochemical parameters, hepatic enzyme activity, lipid profile, oxidative stress, and cognition. The study concluded that VCO could be an effective natural treatment for stress-related changes in brain and liver tissue.", "population_specificity": "Wistar albino rats (150-200 gm)", "effective_dosage": "Not specified", "study_duration": "21 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:10.109820+00:00"}
{"study_id": 9980, "supplement_id": 1034, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to examine the reno-protective benefits of virgin coconut oil (VCO) and GSH, both alone and in combination, in a gentamicin-induced acute renal failure (ARF) rat model.", "results_summary": "The study found that VCO and GSH, especially in combined nanoparticle formulations, significantly improved kidney function markers, reduced oxidative stress and inflammation, and enhanced recovery of renal tissue in ARF. The combination therapy showed better protective effects than either substance alone.", "population_specificity": "Gentamicin-induced ARF rat model", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:10.930460+00:00"}
{"study_id": 9982, "supplement_id": 1034, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers were evaluating the use of a customized clear acrylic stent for neovagina reconstruction in a patient with vaginal agenesis (MRKH syndrome).", "results_summary": "The study found that the customized vaginal stent was a straightforward, cost-efficient, and comfortable solution for neovagina reconstruction, improving patient compliance and quality of life.", "population_specificity": "A 27-year-old female diagnosed with vaginal agenesis (MRKH syndrome).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:12.057513+00:00"}
{"study_id": 9983, "supplement_id": 1034, "safety_score": "70", "efficacy_score": 65, "quality_score": 75, "study_goal": "To determine the efficacy and safety of virgin coconut oil (VCO) as adjunctive therapy for hospitalized COVID-19 patients.", "results_summary": "VCO significantly reduced abnormal CRP levels compared to control but showed no significant benefit in hospital stay duration or symptom resolution. Adverse events were higher in the VCO group.", "population_specificity": "Hospitalized COVID-19 patients at the Philippine General Hospital.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:12.463262+00:00"}
{"study_id": 9981, "supplement_id": 1034, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine whether a Mediterranean diet supplemented with coconut oil increases circulating ketone bodies (KBs) and improves anthropometric variables in ALS patients.", "results_summary": "The study found that a Mediterranean diet supplemented with coconut oil increased circulating KB levels in ALS patients and showed the greatest anthropometric benefits when combined with nicotinamide riboside and pterostilbene. The results suggest coconut oil may provide an alternative energy source for motor neurons.", "population_specificity": "ALS (amyotrophic lateral sclerosis) patients", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:12.737221+00:00"}
{"study_id": 9985, "supplement_id": 1034, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Virgin Coconut Oil (VCO) could mitigate testicular toxicity induced by Sodium Benzoate (SB) by evaluating oxidative stress, inflammation, hormonal levels, and sperm parameters.", "results_summary": "5% VCO restored deranged reproductive hormones and showed stronger antioxidant and anti-inflammatory effects than 15% VCO. Both doses prevented SB-induced sperm function and kinematic impairments.", "population_specificity": "Adult male rats", "effective_dosage": "5% and 15% VCO", "study_duration": "30 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:15.756484+00:00"}
{"study_id": 9984, "supplement_id": 1034, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether virgin coconut oil (VCO), alone or combined with betanin, could regulate NLRP3 inflammasome activity and improve outcomes in aluminum chloride-induced Alzheimer's disease in rats.", "results_summary": "VCO alone or combined with betanin improved cognitive behavior, reduced oxidative stress, inhibited acetylcholinesterase activity, and lowered NLRP3 and IL-1\u03b2 levels in the brain. The combination treatment also reduced neuronal degeneration, amyloid deposition, and necrosis.", "population_specificity": "Wistar rats with aluminum chloride-induced Alzheimer's disease.", "effective_dosage": "VCO at 1 g/kg and 5 g/kg, administered orally.", "study_duration": "42 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:16.180517+00:00"}
{"study_id": 9986, "supplement_id": 1034, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to develop a biocompatible, photo-responsive drug delivery system using chitosan and virgin coconut oil (VCO) for topical applications.", "results_summary": "The study found that the CHT/VCO-based system showed controlled drug release (up to 37% after 48 h) and enhanced antioxidant activity (38.1% after 48 h) due to synergistic effects of curcumin, POM, and VCO. The system exhibited higher water uptake in PBS than in acidic conditions.", "population_specificity": "Not specified (in vitro study).", "effective_dosage": "Not specified.", "study_duration": "48 hours (drying period).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:18.026264+00:00"}
{"study_id": 9988, "supplement_id": 1034, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the potential of Bacillus tropicus in degrading coconut oil cake (COC) for biofuel production, specifically ethanol.", "results_summary": "The study found that B. tropicus effectively degraded COC, increasing cellulase activity and crystallinity index, and achieved a maximum ethanol yield of 4.2 g/L when co-cultured with Saccharomyces cerevisiae.", "population_specificity": "Not applicable (in vitro study using microbial cultures).", "effective_dosage": "Not specified (microbial culture conditions described).", "study_duration": "Not specified (experimental duration not mentioned).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:18.584486+00:00"}
{"study_id": 9990, "supplement_id": 1034, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to validate the effectiveness of virgin coconut oil (VCO) as an adjunct therapy for COVID-19 patients and assess its impact on symptom relief and CRP normalization.", "results_summary": "VCO recipients showed symptom relief and normal CRP levels by day 14, while the control group achieved these outcomes by days 23 and 25, respectively. The study supports VCO as an effective adjunct therapy for mild-to-moderate COVID-19 cases.", "population_specificity": "76 SARS-CoV-2 RT-PCR-confirmed adults with mild-to-moderate symptoms.", "effective_dosage": "Not specified", "study_duration": "28 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:20.522112+00:00"}
{"study_id": 9991, "supplement_id": 1034, "safety_score": "85", "efficacy_score": 90, "quality_score": 75, "study_goal": "The researchers aimed to determine whether virgin coconut oil (VCO) could mitigate neurotoxicity, cognitive impairment, and anxiety-like behavior induced by sodium benzoate in rats.", "results_summary": "VCO supplementation (5% and 15%) significantly reduced oxidative stress and inflammation, improved memory and anxiety-like behavior, and enhanced cholinergic neurotransmission, with 5% VCO showing more pronounced benefits than 15% VCO.", "population_specificity": "Male Wistar rats weighing 160-180g.", "effective_dosage": "5% VCO (mixed with 95g rat chow) and 15% VCO (mixed with 85g rat chow).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:21.727059+00:00"}
{"study_id": 9992, "supplement_id": 1034, "safety_score": "90", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of coconut oil on body weight and other anthropometric parameters compared to palm oil, controlling for confounding variables like total energy intake.", "results_summary": "The study found no significant changes in body weight, BMI, waist circumference, hip circumference, or waist-to-hip ratio after coconut oil consumption compared to palm oil. Both oils showed no impact on anthropometry-related cardiovascular risk factors.", "population_specificity": "37 healthy men and women with a mean age of 39 (\u00b113.1) years.", "effective_dosage": "Pre-determined volume integrated into routine meals and snacks (specific amount not stated).", "study_duration": "8 weeks per oil treatment phase, with a 16-week washout period in between.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:22.269219+00:00"}
{"study_id": 9989, "supplement_id": 1034, "safety_score": "85", "efficacy_score": 70, "quality_score": 90, "study_goal": "The researchers aimed to compare the effects of extra virgin coconut oil (EVCO) with red palm olein (RPOO) and extra virgin olive oil (EVOO) on cardiometabolic risk biomarkers and lipid profile in individuals with central obesity.", "results_summary": "EVCO showed statistically similar effects on plasma high sensitivity C-reactive protein and lipid subfractions compared to RPOO and EVOO, though EVOO resulted in significantly lower LDL cholesterol. EVCO did not exhibit unique adverse effects but also did not outperform the other oils in cardiometabolic benefits.", "population_specificity": "156 individuals with central obesity (waist circumference \u2265 90 cm for men, \u2265 80 cm for women), aged 25-45 years.", "effective_dosage": "Isocaloric diets (~2400 kcal) enriched with EVCO (exact amount not specified).", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:22.471748+00:00"}
{"study_id": 9993, "supplement_id": 1034, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the influence of CBM3 on enzyme variants and their effectiveness in improving oil yield from mature coconut kernels.", "results_summary": "The study found that CBM3 improved enzyme stability, substrate affinity, and catalytic efficiency, leading to enhanced oil yield by up to 22% when treating mature coconut kernels. Structural analyses indicated CBM3's role in maintaining enzyme integrity under certain conditions.", "population_specificity": "Mature coconut kernels (in vitro study, no human or animal subjects).", "effective_dosage": "Not specified (enzyme-assisted treatment details not quantified).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:25.600192+00:00"}
{"study_id": 9994, "supplement_id": 1034, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the remineralizing potential and surface roughness effects of coconut oil, both alone and combined with bioactive glass-ceramic (Biosilicate), on white spot lesions in bovine teeth.", "results_summary": "Coconut oil combined with Biosilicate showed higher surface roughness alteration compared to artificial saliva, but Biosilicate suspension alone was more effective than Biosilicate incorporated into coconut oil for treating white spot lesions. The remineralizing potential of all treatments was similar, though 5% Biosilicate suspension showed higher relative microhardness.", "population_specificity": "Bovine teeth fragments (in vitro study).", "effective_dosage": "Coconut oil alone and with 2% or 5% Biosilicate, applied once daily for 5 minutes.", "study_duration": "14 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:26.765877+00:00"}
{"study_id": 9995, "supplement_id": 1034, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the potential of Perilla meal hydrolysates (PMHs) combined with coconut oil (CO) to generate odor profiles, focusing on volatile compound formation in non-Maillard and Maillard systems.", "results_summary": "The study found that coconut oil significantly increased oxygen, sulfur, and nitrogen-containing volatiles from PMHs in non-Maillard systems, while in Maillard systems, PMHs with 10% CO contributed to the formation of specific volatiles like furan and 2-methylpyrazine. PMHs treated with double enzymes showed higher hydrolysis and antioxidant activity compared to single-enzyme treatments.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "10% (w/w) CO in Maillard system", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:27.585394+00:00"}
{"study_id": 9996, "supplement_id": 1034, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate whether virgin coconut oil (VCO) could enhance clomiphene (CLO) therapy against polycystic ovarian syndrome (PCOS) in female rats.", "results_summary": "VCO demonstrated anti-inflammatory and endocrine-balancing effects, and when combined with CLO, it enhanced reductions in LH, prolactin, testosterone, and oxidative inflammation markers while improving antioxidant gene expression.", "population_specificity": "Female rats with letrozole-induced PCOS.", "effective_dosage": "Not specified in the abstract.", "study_duration": "15 days (days 22 to 36 after PCOS induction).", "interactions": "Synergistic effect with clomiphene noted.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:27.639508+00:00"}
{"study_id": 9999, "supplement_id": 1034, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to analyze the relationship between lipid profiles, fat consumption, and functional disability in MS patients after administering coconut oil and EGCG.", "results_summary": "Coconut oil, combined with EGCG, reduced triglyceride levels in MS patients, which correlated with improved functional disability. The intervention also showed associations between body fat reduction and improved lipid profiles and inflammatory markers.", "population_specificity": "45 patients with multiple sclerosis (MS).", "effective_dosage": "60 mL of coconut oil daily.", "study_duration": "4 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:29.951099+00:00"}
{"study_id": 9997, "supplement_id": 1034, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of coconut oil on cognitive and non-cognitive functions, synaptic transmission, cholinergic activity, neurotrophic factors, and oxidative stress in a rat model of Alzheimer's disease induced by D-GAL and AlCl3.", "results_summary": "Coconut oil attenuated neuropathological changes, including cognitive and non-cognitive impairment, oxidative stress, synaptic transmission deficits, and cholinergic dysfunction in the AD rat model. The treatment showed statistically significant protective effects against AD-related pathology markers.", "population_specificity": "D-GAL/AlCl3-induced Alzheimer's disease rat model.", "effective_dosage": "Not specified.", "study_duration": "90 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:29.999398+00:00"}
{"study_id": 9998, "supplement_id": 1034, "safety_score": "85", "efficacy_score": 60, "quality_score": 80, "study_goal": "The researchers aimed to investigate whether virgin coconut oil (VCO) improves cognition in individuals with mild-to-moderate Alzheimer's disease (AD) and assess the influence of APOE \u025b4 genotype on cognitive outcomes.", "results_summary": "VCO did not significantly improve overall cognition compared to canola oil after 24 weeks, but it improved MMSE scores specifically in APOE \u025b4 carriers. VCO did not negatively affect lipid profiles or HbA1C levels, indicating safety.", "population_specificity": "120 Sri Lankan individuals aged >65 with mild-to-moderate AD (MMSE 15-25).", "effective_dosage": "30 mL/day orally.", "study_duration": "24 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:30.754237+00:00"}
{"study_id": 10000, "supplement_id": 1034, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to assess the impact of a Mediterranean Diet supplemented with coconut oil on anthropometric variables (e.g., muscle mass, fat percentage) in patients with ALS.", "results_summary": "Coconut oil supplementation significantly increased muscle mass percentage and decreased fat mass percentage, subscapular skinfolds, and abdominal skinfolds in ALS patients. The combination of antioxidants and coconut oil also improved muscle mass and reduced abdominal skinfolds.", "population_specificity": "40 subjects with Amyotrophic Lateral Sclerosis (ALS), divided into four study groups.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:31.701366+00:00"}
{"study_id": 10001, "supplement_id": 1034, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to compare the plaque control and anticaries effects of a customized enriched coconut oil formulation (CEC) with Arimedadi Tailam (AT) and chlorhexidine mouth rinse (CHX) in healthy volunteers.", "results_summary": "The study found that CEC oil showed the highest difference in oratest scores, followed by CHX and AT, though no statistically significant differences were observed between groups. Clinically, CEC performed better than AT, but both oils were comparable to CHX for antiplaque and anticaries potential.", "population_specificity": "60 healthy adults aged 18-22 years with DMFT scores of 2-11, zero plaque and gingival indices, and no recent antibiotic or fluoride use.", "effective_dosage": "Not specified", "study_duration": "30 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:35.129291+00:00"}
{"study_id": 10003, "supplement_id": 1034, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the therapeutic effect of coconut oil extracts as an alternative treatment for Cryptosporidium infection in immunocompromised mice.", "results_summary": "Coconut oil extracts significantly reduced oocyst counts and improved histopathological and immunohistochemical changes in ileal tissue, demonstrating potential therapeutic efficacy against Cryptosporidiosis. The results were confirmed through parasitological, histopathological, and immunohistochemical assessments.", "population_specificity": "Immunocompromised mice infected with Cryptosporidium oocysts.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:35.639734+00:00"}
{"study_id": 10004, "supplement_id": 1034, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate whether adding virgin coconut oil (VCO) to atorvastatin therapy improves cardiometabolic outcomes in adults with dyslipidemia.", "results_summary": "Add-on VCO significantly increased HDL and improved oxidative stress cardiovascular risk indices compared to atorvastatin alone, though LDL and total cholesterol reductions were greater in the control group. No significant differences were observed in triglycerides, VLDL, or 10-year cardiovascular risk between groups.", "population_specificity": "150 adults with dyslipidemia", "effective_dosage": "1000 mg/day VCO with 10 mg/day atorvastatin", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:36.591886+00:00"}
{"study_id": 10002, "supplement_id": 1034, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the effect of thermal and nonthermal pre-treatments on the yield and quality of virgin coconut oil (VCO) extracted via wet processing.", "results_summary": "Ultrasonication and pulsed electric field pre-treatments resulted in the highest VCO yields (>93%), with ultrasonication also improving oil quality, including phenolic content and antioxidant levels. Fatty acid composition was studied, confirming the superiority of ultrasonication for both yield and quality.", "population_specificity": "Not specified (laboratory study on coconut cream samples).", "effective_dosage": "Not applicable (pre-treatment conditions: microwave 450 W for 2 min, ohmic 180 V for 5 min, ultrasonication 350 W for 10 min, pulsed electric field 40 kV cm-1 for 12.32 min).", "study_duration": "Single processing session (duration varied by method).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:37.156217+00:00"}
{"study_id": 10006, "supplement_id": 1034, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the effects of virgin coconut oil (VCO), medium-chain triglycerides (MCT), and low lauric acid VCO (LLA) on food intake, body weight, lipid profiles, and hepatic histology in mice fed a high-fat diet.", "results_summary": "VCO and MCT improved liver lipid profiles, while LLA enhanced plasma lipids via a better TC:HDL ratio and showed potential for body weight control. All treatments attenuated high-fat diet-induced hepatic fat accumulation, with VCO being the most effective.", "population_specificity": "Female C57BL/6 mice", "effective_dosage": "Not specified", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:38.493259+00:00"}
{"study_id": 10005, "supplement_id": 1034, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of coconut essential oil on growth performance, carcass criteria, antioxidant status, and immune response in broiler chicks.", "results_summary": "Dietary supplementation with 1 and 1.5 ml/kg of coconut oil significantly improved body weight, liver function, and antioxidant status while reducing triglycerides and VLDL levels. No significant differences were observed in total cholesterol, HDL, or LDL levels.", "population_specificity": "192 un-sexed 7-day-old broiler chicks divided into six treatment groups.", "effective_dosage": "0.5, 1, 1.5, 2, and 2.5 ml of coconut essential oil per kg of feed.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:39.245007+00:00"}
{"study_id": 10008, "supplement_id": 1034, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effectiveness of Virgin Coconut Oil (VCO) and regular repositioning in preventing pressure sores by comparing Braden QD scores before and after intervention.", "results_summary": "The study found a significant improvement in Braden QD scores after applying VCO in the intervention group and repositioning in the control group (p<0.001), suggesting both methods are effective in preventing pressure sores.", "population_specificity": "86 participants selected via nonprobability consecutive sampling, likely patients at risk of pressure ulcers.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:40.020137+00:00"}
{"study_id": 10007, "supplement_id": 1034, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of a metformin-loaded coconut oil nanoemulsion as an anticancer treatment against MCF-7, HepG2, and HCT-116 cancer cell lines.", "results_summary": "The metformin-loaded coconut oil nanoemulsion showed significantly improved anticancer activity compared to non-formulated metformin, with lower IC50 values and increased apoptotic cell percentages in MCF-7 and HepG2 cells. The nanoemulsion demonstrated enhanced drug delivery and efficacy in vitro.", "population_specificity": "Cancer cell lines (MCF-7, HepG2, HCT-116)", "effective_dosage": "0.5% Metformin in the nanoemulsion formulation", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:40.093600+00:00"}
{"study_id": 10010, "supplement_id": 1034, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of virgin coconut oil (VCO) consumption on serum BDNF levels, oxidative stress status, and insulin resistance in adults with metabolic syndrome (MetS).", "results_summary": "VCO consumption significantly reduced oxidative stress markers (MDA) and improved insulin resistance (HOMA-IR, QUICKI) and antioxidant capacity (TAC). It also increased BDNF levels compared to baseline, though not significantly versus the control group.", "population_specificity": "48 adults aged 20-50 years with metabolic syndrome.", "effective_dosage": "30 ml of VCO daily, substituted for the same amount of oil in their usual diet.", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:44.547989+00:00"}
{"study_id": 10009, "supplement_id": 1034, "safety_score": "100", "efficacy_score": 80, "quality_score": 60, "study_goal": "The researchers aimed to scientifically validate the benefits and safety of intra- and peri-vaginal application of virgin coconut oil paste (VCOPF) for treating vaginal dryness and dyspareunia (VDD) in patients with and without rheumatic autoimmune diseases (RAD).", "results_summary": "VCOPF significantly reduced VDD symptoms by 55% in non-RAD and 66% in RAD populations, with efficacy comparable to estrogen-containing therapies and no reported adverse events. The study noted higher baseline and post-treatment pain in non-RAD patients but overall positive outcomes.", "population_specificity": "Women with chronic VDD, including those with and without rheumatic autoimmune diseases (RAD).", "effective_dosage": "Not specified (proprietary brand used via 'CocoRelief' protocol).", "study_duration": "At least six months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:44.958603+00:00"}
{"study_id": 10012, "supplement_id": 1034, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to develop a rapid and accurate analytical technique using FTIR spectroscopy and MCR-ALS to detect adulteration of virgin coconut oil with cheaper vegetable oils.", "results_summary": "The study successfully developed a two-step analytical procedure that distinguished pure virgin coconut oil from adulterated samples with 100% accuracy in external validation. The optimized models effectively quantified adulterants with low error rates (RMSEP < 1.470, absolute errors < 4.6%).", "population_specificity": "Not specified (laboratory-based analysis of oil samples).", "effective_dosage": "Not applicable.", "study_duration": "Not applicable.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:45.502136+00:00"}
{"study_id": 10013, "supplement_id": 1034, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of virgin coconut oil (VCO) on depression and explore its potential mechanisms, including anti-inflammatory and antiapoptotic properties.", "results_summary": "VCO treatment alleviated depressive-like behaviors in rats, reduced neuroinflammation, inhibited microglial and astrocytic activation, and decreased neuronal loss in the hippocampus, possibly by activating the AKT-related pathway.", "population_specificity": "Rat model (animal study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:46.227983+00:00"}
{"study_id": 10011, "supplement_id": 1034, "safety_score": "80", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the cardioprotective role of coconut oil and Coenzyme Q10 in mitigating aluminum phosphide-induced cardiotoxicity, focusing on their antioxidant capacity.", "results_summary": "Coconut oil, alone or combined with CoQ10, improved clinical, laboratory, and ECG parameters in ALP-poisoned patients, with the combination showing superior efficacy in reducing the need for intubation, mechanical ventilation, and vasopressor use. Elevated total antioxidant capacity correlated with improved hemodynamics and reduced cardiotoxicity markers.", "population_specificity": "ALP-poisoned patients admitted to Tanta Poison Control Center.", "effective_dosage": "50 ml coconut oil (single dose for group II; combined with 600 mg CoQ10 for group III, repeated after 12 hours).", "study_duration": "12-hour intervention period.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:46.708593+00:00"}
{"study_id": 10015, "supplement_id": 1034, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 68, "study_goal": "The researchers aimed to identify natural compounds in virgin coconut oil (VCO) with potential to prevent colitis by acting as PPAR-\u03b3 and TNF expression inhibitors.", "results_summary": "The study found that linoleic acid and oleic acid in VCO exhibit anti-inflammatory effects and inhibit TNF expression, with molecular docking showing VCO interacts with the same residues as the control.", "population_specificity": "Children with ulcerative colitis (UC).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:47.589858+00:00"}
{"study_id": 10016, "supplement_id": 1034, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the antioxidant properties of soy protein hydrolysates (SPHs) in oil-in-water emulsions and analyze volatile flavor compounds generated from the thermal reaction of SPHs with coconut oil.", "results_summary": "SPHs prepared with enzymes showed better antioxidant effects in oil-in-water emulsions compared to acid/alkali treatments. Thermal reactions between SPHs and coconut oil produced unique volatile compounds, potentially contributing to flavor in plant protein-based foods.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:48.263798+00:00"}
{"study_id": 10014, "supplement_id": 1034, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether thermosonic treatment combined with green coffee beans could improve the quality, antioxidant capacity, and thermal oxidative stability of coconut oil.", "results_summary": "The study found that treated coconut oil showed significantly increased \u03b2-sitosterol content, improved antioxidant capacity (DPPH and ABTS clearance), and enhanced thermal oxidation stability (higher TG onset temperature and induction time) compared to untreated oil.", "population_specificity": "Not specified (laboratory study, no human or animal subjects mentioned).", "effective_dosage": "Not specified (only ratio of coconut oil to green coffee beans mentioned, no dosage details).", "study_duration": "Not specified (intervention duration not mentioned).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:48.374433+00:00"}
{"study_id": 10018, "supplement_id": 1034, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether coconut oil applied to the nipples during the early postpartum period reduces nipple crack formation and pain.", "results_summary": "The study found that coconut oil significantly reduced nipple crack incidence and pain compared to the control group, with statistically significant differences observed on the 3rd, 7th, and 10th days postpartum.", "population_specificity": "90 postpartum women (30 in the coconut oil group).", "effective_dosage": "Applied to nipples on the 3rd, 7th, and 10th days postpartum (specific quantity not mentioned).", "study_duration": "10 days postpartum.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:53.556160+00:00"}
{"study_id": 10017, "supplement_id": 1034, "safety_score": "85", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to determine the effect of virgin coconut oil (VCO) on lipid profiles and ankle-brachial index (ABI) in patients with Diabetes Mellitus (DM).", "results_summary": "The study found that VCO significantly decreased LDL (p = 0.002), increased HDL (p = 0.031), and reduced energy and cholesterol intake (p = 0.046 and p = 0.023, respectively) after 30 days of use. The therapy was beneficial for maintaining lipid profiles when combined with dietary therapy.", "population_specificity": "Patients with Diabetes Mellitus (DM).", "effective_dosage": "1.2 mL/kgBW daily, divided into three doses.", "study_duration": "30 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:53.821587+00:00"}
{"study_id": 10023, "supplement_id": 1034, "safety_score": "90", "efficacy_score": 75, "quality_score": 65, "study_goal": "To assess the effect of virgin coconut oil (VCO) on nicotine dependence and quality of life when administered for 14 days.", "results_summary": "VCO administration led to a statistically significant decrease in nicotine dependence (0.53 points on FTND) and an improvement in quality of life (5.85 points on EQ-VAS), with all adverse events reported as mild.", "population_specificity": "40 smoking subjects", "effective_dosage": "15 ml twice daily", "study_duration": "14 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:54.835024+00:00"}
{"study_id": 10020, "supplement_id": 1034, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy of virgin coconut oil (VCO) compared to breast milk in treating nipple fissures in primiparous mothers.", "results_summary": "The study found that VCO significantly improved nipple fissures and reduced pain intensity by the 7th and 14th days compared to breast milk, with statistically significant differences between the groups.", "population_specificity": "106 breastfeeding primiparous mothers with nipple fissures in Zarand, Kerman.", "effective_dosage": "0.5 mL of coconut oil applied three times a day.", "study_duration": "14 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:54.897800+00:00"}
{"study_id": 10019, "supplement_id": 1034, "safety_score": "60", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of coconut oil supplementation in rats with metabolic syndrome induced by high fructose feeding, focusing on metabolic and inflammatory outcomes.", "results_summary": "Coconut oil improved glucose homeostasis and reduced fat accumulation but increased triglycerides and fructosamine in serum, along with pro-inflammatory cytokines. It did not prevent oxidative stress or conformational changes in dienes caused by fructose feeding.", "population_specificity": "Rats with fructose-induced metabolic syndrome.", "effective_dosage": "Not specified.", "study_duration": "Long-term (exact duration not specified).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:54.969690+00:00"}
{"study_id": 10022, "supplement_id": 1034, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess the impact of coconut oil combined with EGCG on gait and balance in patients with multiple sclerosis (MS).", "results_summary": "The intervention group showed significant improvements in gait speed, quantitative balance, and right quadriceps muscle strength. Both groups improved in gait resistance, but perceived balance did not change.", "population_specificity": "51 patients with multiple sclerosis (MS).", "effective_dosage": "60 ml of coconut oil daily.", "study_duration": "4 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:55.286727+00:00"}
{"study_id": 10024, "supplement_id": 1034, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of virgin coconut oil (VCO) on stroke incidence, survival, blood pressure, and brain damage in a stroke-prone rat model.", "results_summary": "VCO delayed stroke onset, prolonged survival, lowered blood pressure by 20 mmHg after four weeks, and reduced brain damage compared to the control group.", "population_specificity": "Stroke-prone spontaneously hypertensive rats (SHRSPs)", "effective_dosage": "5 mL/kg/day", "study_duration": "Until stroke occurrence or death (specific duration not stated)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:56.829877+00:00"}
{"study_id": 10025, "supplement_id": 1034, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to isolate a cellulose-degrading yeast (Meyerozyma guillermondii) capable of effectively using coconut oil cake (COC) as a carbon source for cellulase secretion and assess its degradation efficiency.", "results_summary": "M. guillermondii demonstrated high cellulolytic activity (102.96 U/mL CMCase) and effectively degraded COC, as confirmed by FESEM, FTIR, XRD, and color analysis. The study showed significant structural and functional changes in COC after treatment, indicating successful hydrolysis.", "population_specificity": "Not applicable (in vitro study using coconut oil cake and yeast).", "effective_dosage": "Not specified (study focused on degradation efficiency, not dosage).", "study_duration": "5 days (measurement of CMCase activity).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:26:59.704824+00:00"}
{"study_id": 10027, "supplement_id": 1034, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effectiveness of a calcium alginate hydrogel-coated nanofiber system containing coconut oil for controlled drug delivery and wound healing.", "results_summary": "The study found that the nanocomposite hydrogel improved wound healing, was biocompatible, and controlled the release rate of coconut oil over 250 hours. In vivo studies indicated faster skin regeneration.", "population_specificity": "Not specified (likely animal or in vitro models based on context).", "effective_dosage": "Not specified.", "study_duration": "250 hours (drug release study).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:02.128039+00:00"}
{"study_id": 10026, "supplement_id": 1034, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine if topical application of coconut oil improves symptoms of primary mono symptomatic nocturnal enuresis in children.", "results_summary": "The study found that rubbing coconut oil significantly reduced the frequency of enuresis compared to placebo, with effects persisting after one year and no reported side effects requiring medical attention.", "population_specificity": "Children aged 6 to 14 years with mono symptomatic nocturnal enuresis in Yazd, Iran.", "effective_dosage": "6 drops applied topically on suprapubic, sacral, and flanks areas once per night.", "study_duration": "8 weeks of intervention, with follow-up after one year.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:03.012166+00:00"}
{"study_id": 10028, "supplement_id": 1034, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the neuroprotective potential of coconut oil in Parkinson's disease (PD) by examining its effects on oxidative stress, neuroinflammation, mitochondrial dysfunction, apoptosis, and excitotoxicity.", "results_summary": "Coconut oil demonstrated potential neuroprotective effects in PD through multiple pathways, including reducing oxidative stress and neuroinflammation, and providing an alternative energy source via ketone bodies. It was also linked to a decreased incidence of PD in people consuming it through diet.", "population_specificity": "In vitro and in vivo models of Parkinson's disease, with implications for human consumption.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:03.278415+00:00"}
{"study_id": 10031, "supplement_id": 1034, "safety_score": "80", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to analyze the effect of coconut oil intake on cardiometabolic outcomes, including lipid profile, body weight, and glycemic effects, compared to other oils/fats.", "results_summary": "Coconut oil intake showed no significant improvement in body weight, waist circumference, body fat percentage, LDL-C, or triglyceride levels, but was associated with a small increase in HDL-C. The overall risk of bias was high, and the certainty of evidence was very low.", "population_specificity": "Adults (n=515, 50% females)", "effective_dosage": "12-30 ml/day, 6-54.4 g/day, or 15-21% of total caloric energy intake", "study_duration": "4 weeks to 2 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:04.353453+00:00"}
{"study_id": 10030, "supplement_id": 1034, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to compare the acute effects of extra virgin coconut oil (EVCO) and extra virgin olive oil (EVOO) on hunger, metabolic rate, and blood parameters in normal weight and obese subjects.", "results_summary": "EVCO reduced hunger and desire to eat more than EVOO in normal weight subjects, showed a trend in increasing plasma PYY levels, and had no effect on postprandial energy expenditure. Energy intake differences between EVCO and EVOO were not statistically significant.", "population_specificity": "20 metabolically healthy male subjects (10 normal weight, 10 obese) aged 19-40 years.", "effective_dosage": "25 g of EVCO or EVOO consumed once with breakfast.", "study_duration": "Single acute intervention (measured over 180 minutes).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:04.703213+00:00"}
{"study_id": 10029, "supplement_id": 1034, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare ultrasound- and microwave-assisted methods for extracting coconut oil and protein from coconut milk, assessing their efficiency and impact on yield and composition.", "results_summary": "Microwave treatment increased coconut oil extraction yield by ~20%, while ultrasound improved it by 10-16%. Ultrasound also enhanced protein yield (49.6-86.1%) and reduced particle size in coconut milk. Both methods increased phenol liberation in coconut cream.", "population_specificity": "Not specified (laboratory study on coconut milk processing).", "effective_dosage": "Microwave: 1 min (3 pulses of 20 s; 2.5 GHz; 4.31 kW/kg per pulse). Ultrasound: 2.5 min (24 kHz; 0.573 kW/kg; 6.85 W/cm\u00b2).", "study_duration": "Not specified (single treatment session).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:05.314979+00:00"}
{"study_id": 10032, "supplement_id": 1034, "safety_score": "85", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of coconut oil intake combined with diet therapy on anthropometric measurements, biochemical findings, and irisin levels in overweight individuals.", "results_summary": "Coconut oil alone significantly decreased irisin levels but had no impact on anthropometric or biochemical findings. Diet therapy and weight loss did not affect irisin levels, but coconut oil did.", "population_specificity": "Overweight individuals (n=44, aged 19-30) without chronic diseases.", "effective_dosage": "20 mL of coconut oil per day.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:06.200182+00:00"}
{"study_id": 10033, "supplement_id": 1034, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether coconut oil has protective antioxidant and anti-inflammatory effects on alveolar macrophages exposed to particulate matter (PM) and diesel exhaust particles (DEP).", "results_summary": "Coconut oil reversed PM- and DEP-induced cytotoxicity, oxidative stress, and inflammation in alveolar macrophages by regulating the TLR4/MAPK pathway, demonstrating significant anti-inflammatory and antioxidant effects.", "population_specificity": "Alveolar macrophages (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:07.004582+00:00"}
{"study_id": 53837, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate how CPAP affects cerebral and splanchnic tissue oxygenation in preterm infants.", "results_summary": "CPAP did not change mean cerebral oxygenation but reduced its variability and increased cerebral fractional oxygen extraction. Splanchnic oxygenation significantly increased and became more stable with CPAP.", "population_specificity": "Preterm infants (25-37 weeks gestational age at birth).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:14.828542+00:00"}
{"study_id": 53834, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of Continuous Positive Airway Pressure (CPAP) on blood pressure and cortisol levels in postmenopausal women with obstructive sleep apnea (OSA).", "results_summary": "CPAP was found to reduce blood pressure and cortisol levels in postmenopausal women suffering from OSA. The abstract does not provide specific details on the magnitude of these effects or statistical significance.", "population_specificity": "Postmenopausal women with obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:15.281048+00:00"}
{"study_id": 53836, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to determine the effects of an interdisciplinary weight loss and lifestyle intervention on obstructive sleep apnoea (OSA) outcomes, rather than directly evaluating Continuous Positive Airway Pressure.", "results_summary": "The abstract does not provide results regarding Continuous Positive Airway Pressure, as the study focuses on weight loss and lifestyle interventions for OSA.", "population_specificity": "84 males aged 18-65 with a body mass index of \u226525 kg/m\u00b2.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:15.630604+00:00"}
{"study_id": 53838, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether the blood pressure response to Continuous Positive Airway Pressure (PAP) treatment in adults with obstructive sleep apnea (OSA) is related to obesity or urinary norepinephrine levels.", "results_summary": "PAP treatment significantly reduced 24-hour mean arterial pressure in OSA patients, but this effect was not correlated with obesity measures or urinary norepinephrine levels. However, greater reductions in urinary norepinephrine were observed in obese participants compared to non-obese ones.", "population_specificity": "188 adults with obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "4 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:16.357220+00:00"}
{"study_id": 53835, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the impact of introducing CPAP on neonatal survival rates in low-resource settings in Malawi.", "results_summary": "CPAP implementation improved survival to discharge for neonates with respiratory distress (48.6% vs 54.5%), but gains were limited without comprehensive newborn care, especially for small and sick infants.", "population_specificity": "Neonates with admission weights of 1 to 2.49 kg admitted with respiratory illness in 24 government hospitals in Malawi.", "effective_dosage": "Not specified", "study_duration": "15 months immediately after CPAP implementation, with an additional 11-month follow-up.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:16.441211+00:00"}
{"study_id": 53839, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to analyze the effect of continuous positive airway pressure (CPAP) treatment on circulating miRNA profiles in obstructive sleep apnea (OSA) patients and determine if these profiles could help diagnose OSA more accurately.", "results_summary": "CPAP treatment was associated with changes in the circulating miRNA profile, with miRNA levels in the OSA group approximating non-OSA levels after 6 months. A cluster of miRNAs was identified to differentiate between non-OSA and OSA patients, and combining miRNA profiles with the NoSAS-score improved diagnostic accuracy.", "population_specificity": "230 subjects referred to the Sleep Unit due to suspected OSA.", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:16.458965+00:00"}
{"study_id": 53832, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the association between hypovolemia and respiratory variations in pulse pressure (dPP) and photoplethysmographic waveform amplitude (dPOP) during different levels of CPAP and PEP in spontaneously breathing healthy volunteers.", "results_summary": "The study found that dPP and dPOP reflected progressive hypovolemia during CPAP, with dPP increasing at all CPAP levels and dPOP increasing during all CPAP levels. The level of CPAP did not amplify the effect on dPOP.", "population_specificity": "20 healthy volunteers", "effective_dosage": "CPAP of 0, 5, and 10 cmH2O", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:16.708829+00:00"}
{"study_id": 53833, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to summarize recent knowledge about the efficacy and indications of mandibular advancement devices (MADs) as an alternative to continuous positive airway pressure (CPAP) for obstructive sleep apnoea (OSA) patients.", "results_summary": "MADs reduce the apnoea-hypopnoea index, with varying effectiveness among patients, and may improve daytime sleepiness in severe OSA cases and lower blood pressure. However, patient response to therapy in terms of symptom relief and long-term health benefits remains uncertain.", "population_specificity": "Patients with obstructive sleep apnoea (OSA), particularly those who do not tolerate or prefer CPAP, often with comorbidities like cardiovascular diseases, type 2 diabetes, and depression.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:17.538005+00:00"}
{"study_id": 53840, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether hypertension affects cerebral capillary architecture and function in CPAP-treated OSA patients.", "results_summary": "The study found no differences in cerebral microvascular structure and function between hypertensive and normotensive OSA patients treated with CPAP, suggesting controlled hypertension does not impact brain microvascular perfusion.", "population_specificity": "41 middle-aged patients (88% male) with moderate-to-severe OSA, divided into normotensive and hypertensive groups.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:22.985525+00:00"}
{"study_id": 53843, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to compile evidence on the effect of CPAP on insulin resistance in non-diabetic OSA patients.", "results_summary": "CPAP treatment significantly improved the HOMA index but showed no significant changes in fasting glucose. The study suggests CPAP could help halt or regress metabolic disturbances in OSAHS patients with insulin resistance.", "population_specificity": "Non-diabetic adults with obstructive sleep apnea/hypopnea syndrome (OSAHS).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:24.006934+00:00"}
{"study_id": 53846, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare air leaks between fixed-CPAP and auto-CPAP after 4 months of treatment in newly diagnosed OSA patients.", "results_summary": "The study found no impact of CPAP type (fixed vs. auto) on leaks or mask type, but identified CPAP level and oronasal masks as factors associated with leaks. Leaks were standardized using median values across different device brands.", "population_specificity": "Newly diagnosed patients with obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "4 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:24.687716+00:00"}
{"study_id": 53841, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to examine the outcomes of upper airway stimulation (UAS) therapy in patients who failed continuous positive airway pressure (CPAP) therapy for obstructive sleep apnea (OSA).", "results_summary": "UAS therapy significantly improved both objective (AHI reduction from 32.8 to 9.5) and subjective (Epworth Sleepiness Scale improvement from 11.0 to 7.0) OSA outcomes after 12 months, with high adherence (5.6 hours per night). Female sex and lower baseline BMI were predictors of therapy response.", "population_specificity": "Patients with OSA who failed CPAP therapy.", "effective_dosage": "Not specified (UAS therapy usage was 5.6 \u00b1 2.1 hours per night).", "study_duration": "12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:25.233287+00:00"}
{"study_id": 53842, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare changes in lung volumes (functional residual capacity) in premature infants receiving extended CPAP (eCPAP) versus discontinued CPAP (dCPAP) after meeting stability criteria.", "results_summary": "Infants randomized to eCPAP showed a significantly greater increase in FRC compared to dCPAP at 2 weeks (12.6 mL vs 6.4 mL) and through discharge (27.2 mL vs 17.1 mL), suggesting improved respiratory health with extended CPAP use.", "population_specificity": "Premature infants born at \u226432 weeks of gestation requiring \u226524 hours of CPAP.", "effective_dosage": "Not specified (CPAP stability criteria determined intervention).", "study_duration": "2 weeks of eCPAP vs. discontinuation (dCPAP).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:25.311400+00:00"}
{"study_id": 53844, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to characterize the haemodynamic changes accompanying the first dose of minimally invasive surfactant therapy (MIST) combined with continuous positive airway pressure (CPAP) in preterm infants.", "results_summary": "The study found significant improvements in pulmonary blood flow, reduced pulmonary vascular resistance, and enhanced ventricular function after MIST with CPAP, along with a notable decrease in FiO2 requirements. These changes suggest effective cardiovascular adaptation to the combined therapy.", "population_specificity": "Preterm infants (mean gestational age 29.5 \u00b1 2.8 weeks, median birth weight 1,102 g).", "effective_dosage": "Poractant alfa (200 mg/kg) administered once as MIST.", "study_duration": "Echocardiograms were performed before and at 30 and 60 minutes after MIST.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:26.554244+00:00"}
{"study_id": 53845, "supplement_id": 1048, "safety_score": "85", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to compare the feasibility of noninvasive neurally adjusted ventilatory assist (NIV NAVA) and continuous positive airway pressure (CPAP) in preterm newborn infants with respiratory distress.", "results_summary": "The study found no significant difference in oxygen requirements or the need for invasive ventilation between NIV NAVA and CPAP groups. Both treatments showed similar efficacy in managing respiratory distress in preterm infants.", "population_specificity": "Preterm infants (gestational age 28+0 to 36+6 weeks) with respiratory distress requiring CPAP and supplemental oxygen (FiO2 >0.23) at <48 h of postnatal age.", "effective_dosage": "Not specified (standard CPAP and NIV NAVA protocols used).", "study_duration": "Primary endpoint assessed at 12 hours; total duration of respiratory support varied by patient.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:26.827226+00:00"}
{"study_id": 53847, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the outcomes of very-low-birth-weight neonates before and after the introduction of low-cost bubble continuous positive airway pressure (bCPAP) for treating respiratory distress syndrome in a low-income country setting.", "results_summary": "The study found a significant reduction in mortality (from 39.2% to 26.5%) after the introduction of bCPAP, with an overall 44% reduction in mortality. No differences in birthweight, sex, or respiratory distress signs were observed between the pre- and post-bCPAP groups.", "population_specificity": "Very-low-birth-weight neonates (<1500 g) with respiratory distress syndrome in a neonatal unit in eastern Uganda.", "effective_dosage": "Not specified", "study_duration": "18 months post-bCPAP introduction", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:27.354294+00:00"}
{"study_id": 53849, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the literature on noninvasive respiratory support strategies, including Continuous Positive Airway Pressure, to determine which therapy provides optimal support.", "results_summary": "The abstract does not specify findings related to Continuous Positive Airway Pressure, only that it reviewed important literature on noninvasive respiratory support published in 2018.", "population_specificity": "Not specified in the abstract.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:31.527948+00:00"}
{"study_id": 53848, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the association between floppy eyelid syndrome (FES) and obstructive sleep apnea (OSA), and evaluate the potential benefits of treating OSA with continuous positive airway pressure (CPAP) for improving FES.", "results_summary": "The study found that treating OSA with CPAP or surgical uvulopalatoplasty may improve FES, suggesting a potential therapeutic benefit. However, the abstract does not provide specific efficacy data or statistical significance for CPAP's effects on FES.", "population_specificity": "Patients with floppy eyelid syndrome (FES) and obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:31.938606+00:00"}
{"study_id": 53850, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine whether CPAP therapy reduces visceral adipose tissue (VAT) in patients with obstructive sleep apnea (OSA).", "results_summary": "The meta-analysis found no significant change in VAT before and after CPAP treatment in OSA patients, with subgroup analyses confirming that various factors did not influence the outcome. The study concluded that CPAP therapy does not affect VAT in OSA patients.", "population_specificity": "398 patients with obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:32.569914+00:00"}
{"study_id": 53852, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review contemporary methods of surfactant administration, including the use of Continuous Positive Airway Pressure (CPAP), in preterm infants with respiratory distress syndrome.", "results_summary": "The study highlights that CPAP-supported surfactant administration via thin catheter is becoming widely adopted in neonatal intensive care units as an effective alternative to traditional methods, though newer techniques like aerosolisation remain under research.", "population_specificity": "Preterm infants with respiratory distress syndrome.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:32.972146+00:00"}
{"study_id": 53854, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to identify early predictive factors for failure of the INSURE procedure in preterm infants with respiratory distress syndrome (RDS).", "results_summary": "The study found that extremely low birth weight, low gestational age, and severe RDS appear to be risk factors for INSURE failure, though evidence was inconsistent due to methodological heterogeneity. The clinical applicability of these results is limited, highlighting the need for future large cohort studies.", "population_specificity": "Preterm infants with respiratory distress syndrome (RDS).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:34.233797+00:00"}
{"study_id": 53853, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine whether hyperaldosteronemia occurs in patients with OSAHS and T2DM and whether CPAP treatment reduces aldosterone levels.", "results_summary": "CPAP treatment significantly reduced plasma aldosterone and renin levels in OSAHS patients with T2DM, though levels remained higher than controls. Urinary aldosterone levels post-treatment were still higher in the OSAHS group than controls, and no significant change in blood glucose was observed.", "population_specificity": "Patients with type 2 diabetes mellitus (T2DM) and obstructive sleep apnea\u2013hypopnea syndrome (OSAHS).", "effective_dosage": "7 hours/day", "study_duration": "7 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:34.240508+00:00"}
{"study_id": 53855, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to identify clinical factors, including CPAP use, associated with COPD exacerbations and all-cause mortality in patients with COPD-OSA overlap syndrome.", "results_summary": "The study found that CPAP use was independently associated with reduced COPD exacerbations and lower all-cause mortality in overlap syndrome patients. Poor CPAP adherence correlated with worse outcomes.", "population_specificity": "Patients with chronic obstructive pulmonary disease (COPD) and obstructive sleep apnoea (OSA) overlap syndrome.", "effective_dosage": "Not specified", "study_duration": "42-month retrospective evaluation", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:34.935658+00:00"}
{"study_id": 53856, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to compare the effectiveness of non-invasive ventilation (NIV) modalities, including nasal continuous positive airway pressure (NCPAP), for managing respiratory distress syndrome (RDS) in preterm infants.", "results_summary": "The study found that NIPPV showed considerable benefits over NCPAP, while HHHFNC had high treatment failure rates. Combining the INSURE technique with NIV improved success rates in RDS management.", "population_specificity": "Preterm infants with respiratory distress syndrome (RDS).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:35.596253+00:00"}
{"study_id": 53858, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to explore how Big Data can enhance understanding, diagnosis, and personalized treatment of sleep apnoea, particularly focusing on the role of Positive Airway Pressure (PAP) devices.", "results_summary": "The abstract highlights that PAP devices generate vast amounts of data, which can improve sleep-disordered breathing understanding, personalize treatment, and optimize health policies. Challenges include data management, collaboration between scientists and physicians, and ethical considerations.", "population_specificity": "Patients with sleep apnoea globally, using PAP devices long-term.", "effective_dosage": "Not specified", "study_duration": "Long-term use (implied by \"every night over long periods\")", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:40.487202+00:00"}
{"study_id": 53857, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare the need for mechanical ventilation between administering surfactant via a thin catheter during spontaneous breathing (SurE) and the traditional intubation surfactant and extubation technique (InSurE) in preterm infants with RDS on CPAP.", "results_summary": "The SurE technique significantly reduced the need for mechanical ventilation within the first 72 hours (19% vs. 40%), shortened oxygen therapy and hospital stay durations, and lowered the bronchopulmonary dysplasia (BPD) rate compared to the InSurE technique.", "population_specificity": "Preterm infants \u226434 weeks with respiratory distress syndrome (RDS) requiring CPAP within 6 hours of life.", "effective_dosage": "Not specified", "study_duration": "Intervention effects were assessed within the first 72 hours of life.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:41.763334+00:00"}
{"study_id": 53859, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to determine if Bilevel Positive Airway Pressure (BPAP) could improve treatment adherence and outcomes in patients with obstructive sleep apnea (OSA) who failed Continuous Positive Airway Pressure (CPAP) therapy.", "results_summary": "The study found that BPAP was well tolerated and achieved sufficient control of sleep-disordered breathing and its symptoms in patients with moderate-severe OSA who had low adherence to CPAP.", "population_specificity": "Patients with OSA who failed CPAP therapy (usage <4 h/day) and were referred to a tertiary sleep center between 2014 and 2017.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:42.106682+00:00"}
{"study_id": 53862, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to assess the feasibility and impact of educational materials on CPAP adherence and outcomes in stroke/TIA patients with OSA.", "results_summary": "The educational program was well-received and easy to understand but did not significantly improve knowledge, daytime sleepiness, functional outcomes, or CPAP use at 6 months. No significant difference in CPAP adherence was observed between the intervention and control groups.", "population_specificity": "Stroke and transient ischemic attack (TIA) patients with obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:42.922522+00:00"}
{"study_id": 53861, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "To evaluate the use of noninvasive positive pressure ventilation (NIPPV) in reducing oxygen desaturation events during esophagogastroduodenoscopy (EGD) among patients with severe obesity.", "results_summary": "NIPPV significantly reduced oxygen desaturation events \u226494% (14.3% vs. 57.1%) and events <90% requiring intervention (3.5% vs. 28.6%) compared to the control group. All control group patients requiring intervention were successfully rescued with NIPPV.", "population_specificity": "Patients with severe obesity (BMI 40-60) undergoing EGD.", "effective_dosage": "Not specified", "study_duration": "Duration of EGD procedure (exact time not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:44.886413+00:00"}
{"study_id": 53864, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate whether a telemedicine concept (telemonitoring and support calls) could improve adherence to Continuous Positive Airway Pressure (PAP) therapy in stroke patients with moderate to severe obstructive sleep apnea (OSA).", "results_summary": "The telemedicine care (TC) group showed significantly higher PAP therapy adherence (4.4 \u00b1 2.5 h/night) compared to standard care (SC) (2.1 \u00b1 2.2 h/night) after 6 months. Additionally, the TC group exhibited reduced sleepiness and lower systolic blood pressure in a subgroup analysis.", "population_specificity": "PAP-naive stroke patients with an apnea-hypopnea index (AHI) >15.", "effective_dosage": "Not specified (usage monitored, but no fixed dosage mentioned).", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:46.131131+00:00"}
{"study_id": 53863, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to compare treatment failure rates between nasal continuous positive airway pressure (NCPAP) and noninvasive neurally adjusted ventilatory assist (NIV-NAVA) in infants with respiratory distress after birth.", "results_summary": "No significant difference in treatment failure rates was observed between NCPAP and NIV-NAVA groups. However, the duration of mechanical ventilation was significantly longer in the NCPAP group.", "population_specificity": "Infants with birth weights \u22641500\u2009g and respiratory distress receiving noninvasive respiratory support within \u226448\u2009hours of life.", "effective_dosage": "Not specified", "study_duration": "\u226472\u2009hours for primary outcome assessment; noninvasive support duration varied (147\u2009\u00b1\u2009181\u2009hours for NCPAP, 127\u2009\u00b1\u2009137\u2009hours for NIV-NAVA).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:46.602273+00:00"}
{"study_id": 53868, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 40, "study_goal": "The researchers aimed to evaluate whether positioning therapy without mechanical ventilation could resolve unilateral pulmonary interstitial emphysema (PIE) in very preterm infants exposed to nasal continuous positive airway pressure (CPAP).", "results_summary": "The study reported complete resolution of unilateral PIE in a very preterm infant through positioning therapy on the affected hemithorax without mechanical ventilation, suggesting it as a viable therapeutic option.", "population_specificity": "Very low birth weight infants (specifically a 28-week preterm infant) with unilateral pulmonary interstitial emphysema (PIE).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:50.835675+00:00"}
{"study_id": 53867, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the association between chronic kidney disease (CKD) and obstructive sleep apnea (OSA), focusing on epidemiology, pathophysiology, and the potential effects of CPAP on renal function.", "results_summary": "The abstract suggests CPAP improves OSA symptoms and quality of life, with recent studies indicating potential benefits for kidney function in OSA patients. However, the review is narrative and does not present new experimental data.", "population_specificity": "Patients with obstructive sleep apnea (OSA), particularly those with chronic kidney disease (CKD) or end-stage renal disease (ESRD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:51.862739+00:00"}
{"study_id": 53866, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare the treatment efficacy and adherence between the NightBalance sleep position treatment (SPT) device and auto-adjusting positive airway pressure (APAP) in patients with exclusive positional obstructive sleep apnea (ePOSA).", "results_summary": "The study found that SPT resulted in non-inferior treatment efficacy and greater adherence compared to APAP in ePOSA patients, suggesting SPT is an effective treatment for this group. The AHI on SPT was higher than APAP, but adherence was better with SPT.", "population_specificity": "Treatment-naive participants with exclusive positional obstructive sleep apnea (ePOSA), defined as a supine apnea-hypopnea index (sAHI) \u2265 2 times the nonsupine AHI (nsAHI) and nsAHI < 10 events/h.", "effective_dosage": "Not specified", "study_duration": "6 weeks per treatment (crossover design)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:52.667755+00:00"}
{"study_id": 53860, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether cognitive and behavioral therapy for insomnia (CBT-i) prior to CPAP therapy improves CPAP adherence and insomnia symptoms in patients with comorbid OSA and insomnia compared to standard treatment.", "results_summary": "CBT-i before CPAP therapy led to 61 minutes greater nightly CPAP adherence, higher initial CPAP acceptance (99% vs. 89%), and greater improvement in insomnia severity and dysfunctional sleep-related cognitions compared to treatment as usual. No differences were found in sleep outcomes or daytime impairments by 6 months.", "population_specificity": "Adults with OSA (apnea-hypopnea index \u2265 15) and comorbid insomnia.", "effective_dosage": "Not specified (CPAP settings not detailed in abstract).", "study_duration": "6 months post-randomization.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:53.671687+00:00"}
{"study_id": 53870, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Continuous Positive Airway Pressure (CPAP) treatment influences adverse events and outcomes in patients with acute coronary syndrome (ACS) and obstructive sleep apnoea (OSA).", "results_summary": "The study found mixed results regarding CPAP's efficacy; randomized controlled trials in non-sleepy OSA patients with stable coronary artery disease showed no cardiovascular protection, while uncontrolled studies suggested positive effects. Data on CPAP's impact in ACS patients with OSA are limited, with randomized controlled study results pending.", "population_specificity": "Patients with obstructive sleep apnoea (OSA), including those with stable coronary artery disease and acute coronary syndrome (ACS).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:54.406057+00:00"}
{"study_id": 53871, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the time healthcare workers spent administering bCPAP versus low-flow nasal oxygen for children with severe pneumonia in a low-resource setting.", "results_summary": "bCPAP required significantly more time (34.71 minutes more per patient) to initiate compared to low-flow nasal oxygen, with additional time spent on equipment setup and adjustments during maintenance care.", "population_specificity": "Children aged 1-59 months with WHO-defined severe pneumonia and HIV-infection, HIV-exposure, severe malnutrition, or hypoxemia in Malawi.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:55.301352+00:00"}
{"study_id": 53872, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the effectiveness and safety of CPAP, NIPPV, and NHFOV in preterm neonates during their entire stay in neonatal intensive care units.", "results_summary": "The study found that CPAP is commonly used but NIPPV may be more efficacious in the early post-extubation phase, while NHFOV might be beneficial for babies needing high constant distending pressure. Long-term outcomes for NIPPV and NHFOV remain unclear due to limited data.", "population_specificity": "Preterm neonates in neonatal intensive care units in China.", "effective_dosage": "Not specified", "study_duration": "Entire stay in neonatal intensive care units (potentially several weeks)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:55.370663+00:00"}
{"study_id": 53873, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the effectiveness of nasal high-flow therapy (nHF) and continuous positive airway pressure (CPAP) for respiratory support in preterm infants, particularly focusing on primary support for respiratory distress syndrome.", "results_summary": "The study found that CPAP is superior to nHF for primary support of respiratory distress syndrome in preterm infants, though nHF remains a reasonable alternative for postextubation support. Minimal evidence supports nHF use in extremely preterm infants (<28 weeks' gestation).", "population_specificity": "Preterm infants, including extremely preterm infants (<28 weeks' gestation).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:59.355272+00:00"}
{"study_id": 53874, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of Continuous Positive Airway Pressure (CPAP) in treating respiratory distress syndrome in preterm infants and its role alongside other therapies like antenatal steroids and exogenous surfactant.", "results_summary": "The study found that CPAP is effective in treating respiratory distress syndrome in preterm infants, potentially reducing the need for exogenous surfactant. Combining CPAP with other therapies may further improve clinical outcomes.", "population_specificity": "Preterm infants", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:27:59.675517+00:00"}
{"study_id": 53877, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of 8-week CPAP treatment on oxidative stress, inflammatory markers, and cell-free DNA levels in moderate to severe OSA patients.", "results_summary": "CPAP did not significantly alter oxidative stress, inflammatory markers, or cell-free DNA levels but improved self-reported sleep quality and sleep efficiency. AOPP and IL-17A levels increased with CPAP, particularly without a humidifier.", "population_specificity": "39 patients with moderate to severe obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:02.259155+00:00"}
{"study_id": 53876, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to assess the effect of CPAP therapy on biomarkers of inflammation, antioxidant activity, and depression in women with moderate-to-severe obstructive sleep apnea (OSA).", "results_summary": "The study found no significant changes in biomarkers of inflammation, antioxidant activity, or depression after 12 weeks of CPAP therapy compared to conservative treatment, except for a slight decrease in TNF\u03b1 levels in women who used CPAP for at least 5 hours per night.", "population_specificity": "247 women with moderate-to-severe OSA (AHI \u2265 15), median age 58 years, BMI 33.5 kg/m\u00b2.", "effective_dosage": "CPAP use at least 5 hours per night (specific pressure settings not mentioned).", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:02.927495+00:00"}
{"study_id": 53875, "supplement_id": 1048, "safety_score": "75", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to compare patient acceptability, safety, and effects on pain and pulmonary function between nocturnal auto-adjusting continuous positive airway pressure (APAP) and nocturnal oxygen therapy (NOT) in individuals with sickle cell anaemia.", "results_summary": "APAP was preferred by 62.5% of participants, with no significant differences in haematology, pulmonary function, or pain days between APAP and NOT. Both interventions showed a decrease in median pain days compared to baseline, but no significant difference was found between them.", "population_specificity": "Adults and children (aged >8 years) with sickle cell anaemia.", "effective_dosage": "Not specified (nocturnal use for 7 days).", "study_duration": "7 days per intervention (with a washout period).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:03.259879+00:00"}
{"study_id": 53879, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of BIPAP and AVAPS modalities on pH, gas variation, and patient comfort in patients with acute respiratory failure.", "results_summary": "The study found that AVAPS modality significantly improved pH levels and patient compliance compared to BIPAP, with statistically significant results (p=0.001 for pH changes, p=0.015, p=0.008, p=0.008 for compliance).", "population_specificity": "30 patients with acute respiratory failure due to internal or postoperative reasons.", "effective_dosage": "Not specified", "study_duration": "2 hours per modality (BIPAP followed by AVAPS)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:03.588180+00:00"}
{"study_id": 53880, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 80, "study_goal": "The researchers aimed to determine whether sleep-study guided multidisciplinary therapy (SGMT), including Continuous Positive Airway Pressure (CPAP), could reduce cardiovascular biomarkers in patients with acute coronary syndrome and obstructive sleep apnoea (OSA).", "results_summary": "The study found no significant difference in cardiovascular biomarker levels (NT-proBNP, ST2, hs-CRP) between patients receiving SGMT (including CPAP) and standard therapy after 7 months, suggesting CPAP did not provide additional biomarker reduction in this population.", "population_specificity": "Patients presenting with acute coronary syndrome and diagnosed with mild, moderate, or severe OSA.", "effective_dosage": "Not specified", "study_duration": "7 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:05.370267+00:00"}
{"study_id": 53882, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to determine how CPAP treatment for obstructive sleep apnea (OSA) impacts cerebral vascular dynamics and whether it reduces the risk of ischemic stroke.", "results_summary": "After CPAP treatment, mean blood flow velocity (MBFV) and breath holding index (BHI) increased (though not statistically significant), while carotid intima-media thickness (cIMT) and polysomnographic parameters significantly decreased, suggesting improved cerebral vasoreactivity and reduced stroke risk.", "population_specificity": "40 untreated patients with moderate to severe obstructive sleep apnea.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:07.689612+00:00"}
{"study_id": 53881, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the impact of CPAP and/or rehabilitation on sleep parameters, neurological recovery, and functional outcomes in basal ganglia stroke patients with obstructive sleep apnea (OSA).", "results_summary": "The CPAP group showed significant improvements in sleep parameters (e.g., reduced AHI, improved oxygen saturation), neurological function (NIHSS, FMA), daily activities (BI), cognitive function (MMSE), and psychological states (HAMA, HRSD) compared to the control group over 2 years. No significant difference in BMI management was observed.", "population_specificity": "Basal ganglia stroke patients with obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Up to 2 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:08.632545+00:00"}
{"study_id": 53883, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the effectiveness of Less Invasive Surfactant Administration (LISA) with standard CPAP treatment and the INSURE procedure in premature infants with respiratory distress syndrome.", "results_summary": "The study found that LISA is more effective than standard treatment or INSURE in avoiding mechanical ventilation (short-term) and reducing intracerebral hemorrhage and bronchopulmonary dysplasia (long-term). Open questions remain about treatment thresholds, device usefulness, and analgesia during the procedure.", "population_specificity": "Premature infants with respiratory problems, particularly those with surfactant deficiency.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:10.789863+00:00"}
{"study_id": 53865, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to examine the effect of the CPAP-SAVER intervention on adherence among adults with newly diagnosed obstructive sleep apnea (OSA).", "results_summary": "The study compared CPAP-SAVER intervention with standard care in 66 participants randomly assigned to each group, analyzing adherence data using chi-square. The abstract does not provide specific outcome details.", "population_specificity": "Adults with newly diagnosed obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:11.323646+00:00"}
{"study_id": 53884, "supplement_id": 1048, "safety_score": "85", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to determine whether high-flow nasal cannula (HFNC) could prevent delays in oral feeding and achievement of full oral feeding in very-low-birth-weight infants (VLBWIs) with chronic lung disease (CLD), compared to nasal continuous positive airway pressure (nCPAP).", "results_summary": "The study found no significant differences in the timings of oral feeding initiation and full oral feeding achievement between the HFNC and non-HFNC groups. However, HFNC was associated with no clinically significant aspiration pneumonia, suggesting it might be safe and could accelerate oral feeding milestones in VLBWIs with CLD.", "population_specificity": "Very-low-birth-weight infants (VLBWIs) with chronic lung disease (CLD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:12.284007+00:00"}
{"study_id": 53887, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether CPAP therapy improves left ventricular (LV) and right ventricular (RV) mechanical function in patients with severe obstructive sleep apnea (OSA) compared to a sham intervention.", "results_summary": "CPAP treatment significantly improved LV global longitudinal strain (GLS) and RV fractional area change compared to sham treatment, though it did not affect LV dimensions, ejection fraction, or RV GLS.", "population_specificity": "Patients with severe OSA (n=52).", "effective_dosage": "Not specified", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:12.817263+00:00"}
{"study_id": 53886, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "To compare the effects of nasal high flow (NHF) and continuous positive airway pressure (CPAP) on end-expiratory level, continuous distending pressure, and regional ventilation distribution in preterm infants.", "results_summary": "NHF at flow rates of 2-6 L/min was as effective as CPAP in maintaining end-expiratory level and ventilation distribution, but CPAP provided better overall oxygenation. No significant differences in ventilation distribution, EEL, or CDP were found between CPAP and NHF.", "population_specificity": "Preterm infants requiring CPAP respiratory support in a Neonatal Intensive Care Unit (mean corrected age: 31.19 \u00b1 1.17 weeks).", "effective_dosage": "NHF flow rates of 2, 4, and 6 L/min compared with bubble CPAP.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:13.729495+00:00"}
{"study_id": 53885, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the effectiveness of autoadjusting continuous positive airway pressure (APAP) in improving post-stroke recovery for high-risk obstructive sleep apnea (OSA) patients, using overnight oximetry for risk stratification.", "results_summary": "APAP treatment was poorly tolerated (only 10% compliance) and showed no clinically meaningful improvement in functional recovery post-stroke, with no significant differences in functional independence measure (FIM) scores between adherent and non-adherent patients. A subgroup analysis revealed a statistically significant but clinically irrelevant difference in FIM change.", "population_specificity": "Post-stroke patients at an academic inpatient stroke rehabilitation facility, high-risk for OSA (oxygen desaturation index 3% > 10 per hour).", "effective_dosage": "Not specified (APAP usage > 4 h/night on > 70% of nights for compliance).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:13.924452+00:00"}
{"study_id": 53888, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate strategies to improve adherence to Continuous Positive Airway Pressure (CPAP) and oral appliance (OA) therapy for sleep-disordered breathing (SDB).", "results_summary": "The study found that CPAP is highly effective for treating SDB but adherence remains sub-optimal. A multidimensional approach targeting disease characteristics, patient factors, treatment protocols, and device-related issues is likely needed to improve adherence.", "population_specificity": "Patients with sleep-disordered breathing (SDB).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:15.596315+00:00"}
{"study_id": 53889, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to compare hospital reimbursement rates for inpatient bronchiolitis treatment between pediatric intensive care unit (PICU) and ward admissions, and assess their alignment with nursing intensity scores.", "results_summary": "The study found that reimbursement claims for PICU admissions were three times higher than ward admissions, but these claims did not correlate with nursing intensity scores. Median costs were \u20ac6352 for PICU cases and \u20ac2009 for ward cases, with longer hospital stays in the PICU (8.5 days vs. 3 days).", "population_specificity": "Children under 12 months of age treated for bronchiolitis in a PICU (n=44) or on the ward (n=88) between 2010-2015.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:18.149346+00:00"}
{"study_id": 53890, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the mechanisms, efficacy, and long-term outcomes of noninvasive respiratory support methods, including nasal continuous positive airway pressure, for preterm infants with respiratory distress syndrome.", "results_summary": "Noninvasive ventilation, including continuous positive airway pressure, can reduce intubation and invasive ventilation needs in preterm infants with respiratory distress syndrome, but it does not decrease rates of bronchopulmonary dysplasia.", "population_specificity": "Preterm infants, particularly very low birthweight infants with respiratory distress syndrome.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:18.478294+00:00"}
{"study_id": 53891, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the accuracy of lung ultrasonography (LUS) in identifying infants with respiratory distress who require surfactant treatment or mechanical ventilation while on nasal continuous positive airway pressure (NCPAP).", "results_summary": "The study found that LUS, particularly an LUS score >5-6, accurately identified infants needing surfactant or mechanical ventilation, with pooled sensitivity of 88% and specificity of 82%. The accuracy was higher in younger preterm infants compared to late preterm and term infants.", "population_specificity": "Infants with respiratory distress treated with NCPAP (485 infants across six studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:19.971669+00:00"}
{"study_id": 53892, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to explore factors influencing treatment adherence for obstructive sleep apnoea (OSA), focusing on personality traits, psychological readiness, and barriers to using continuous positive airway pressure (CPAP).", "results_summary": "The study highlights that low self-efficacy and personality traits impact CPAP adherence, identifying vulnerable groups needing additional support. It summarizes current evidence on treatment barriers but does not provide new efficacy data for CPAP itself.", "population_specificity": "Patients with obstructive sleep apnoea (OSA), particularly those with mild-to-moderate cases or difficulty tolerating mechanical treatments.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:20.850843+00:00"}
{"study_id": 53893, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to characterize access and adherence to positive airway pressure (PAP) treatment in patients with moderate-severe obstructive sleep apnea (OSA) across Latin America.", "results_summary": "Less than half of moderate-severe OSA patients initiated and continued PAP therapy, with unclear/absent medical indication and financial limitations being the primary barriers to access. The study did not report specific efficacy outcomes of PAP treatment itself.", "population_specificity": "Adults with moderate-severe OSA (AHI \u2265\u200915/h) from Argentina, Brazil, Chile, Colombia, Mexico, and Peru.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:21.580747+00:00"}
{"study_id": 53895, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to assess the relationship between hypoxemia, endothelial dysfunction (ED), and BK \u03b21-subunit mRNA expression in normotensive OSA patients, and evaluate the impact of CPAP treatment on ED and \u03b21-subunit regulation.", "results_summary": "CPAP improved endothelial function in normotensive OSA patients, with the speed of arterial response significantly correlated with \u03b21-subunit mRNA expression. \u03b21-subunit mRNA expression at baseline inversely correlated with its change after CPAP.", "population_specificity": "Normotensive patients with severe obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:22.475182+00:00"}
{"study_id": 53894, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to assess the safety and efficacy of hypoglossal nerve stimulation as an alternative therapy for children with Down syndrome and refractory severe OSA who had failed continuous positive airway pressure therapy.", "results_summary": "The study found that hypoglossal nerve stimulation was safe and effective, with an 85% median reduction in AHI and high adherence (9.21 hours/night). Two minor surgical complications occurred but were corrected.", "population_specificity": "Nonobese children and adolescents (aged 10-21 years) with Down syndrome and severe OSA (AHI >10 and <50 events/hr) who failed prior adenotonsillectomy and continuous positive airway pressure therapy.", "effective_dosage": "Not specified", "study_duration": "2-month follow-up", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:23.284317+00:00"}
{"study_id": 53896, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate factors associated with progression from resistant hypertension to refractory hypertension, including the role of poor adherence to CPAP in obstructive sleep apnea.", "results_summary": "Poor adherence to CPAP was identified as a significant prognostic factor for progression to refractory hypertension (OR: 3.36, 95% CI: 1.47-7.7, p = 0.004). The study suggests that untreated obstructive sleep apnea or poor CPAP adherence contributes to worsening hypertension.", "population_specificity": "Patients with resistant hypertension (172 participants across 24 centers) confirmed via 24-hour ambulatory blood pressure monitoring.", "effective_dosage": "Not specified", "study_duration": "Mean follow-up of 57 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:24.554667+00:00"}
{"study_id": 53897, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effect of various OSAS treatments, including CPAP, on endothelial function measured by flow-mediated dilatation (FMD).", "results_summary": "The meta-analysis found that OSAS treatments, including CPAP, significantly improved endothelial function (MD = 2.58; 95% CI 1.95-3.20; p < 0.00001). The study supports the hypothesis that OSAS treatments positively impact endothelial function, though clinical outcome improvements remain unconfirmed.", "population_specificity": "Patients with mild to severe obstructive sleep apnoea syndrome (OSAS).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:27.052233+00:00"}
{"study_id": 53898, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the association between obstructive sleep apnoea (OSA) and refractory hypertension (RfH) and assess the effectiveness of continuous positive airway pressure (CPAP) in reducing blood pressure in RfH patients.", "results_summary": "The study found a high prevalence of OSA in RfH patients and demonstrated that CPAP treatment significantly reduces blood pressure levels, particularly during nighttime, in this population. The effect was greater in RfH patients compared to those with resistant (non-refractory) hypertension.", "population_specificity": "Patients with refractory hypertension (RfH), defined as uncontrolled blood pressure despite using \u22655 antihypertensive drugs at optimal doses.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:27.624852+00:00"}
{"study_id": 53899, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to assess the effect of CPAP treatment on clinical, quality-of-life, and neurocognitive measures in elderly patients with moderate OSA.", "results_summary": "The abstract does not provide specific results, but the study was designed to evaluate CPAP's impact in elderly patients with moderate OSA using an open-label, randomized, multicenter clinical trial.", "population_specificity": "Elderly patients (\u226570 years old) with moderate OSA (apnoea-hypopnoea index 15-29.9 events\u00b7h).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:27.887134+00:00"}
{"study_id": 53900, "supplement_id": 1048, "safety_score": "85", "efficacy_score": 80, "quality_score": 90, "study_goal": "The researchers aimed to compare the efficacy and safety of nasal masks versus binasal prongs for delivering NCPAP in preterm infants under 37 weeks of gestation.", "results_summary": "Nasal masks reduced NCPAP failure within 72 hours, nasal injury incidence, moderate-to-severe bronchopulmonary dysplasia, and the need for surfactant administration compared to binasal prongs, though evidence certainty was low to very low.", "population_specificity": "Preterm infants under 37 weeks of gestation requiring NCPAP.", "effective_dosage": "Not specified", "study_duration": "Outcomes assessed within 72 hours and longer-term effects like bronchopulmonary dysplasia.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:29.969254+00:00"}
{"study_id": 53902, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of early or prophylactic Continuous Positive Airway Pressure (CPAP) in preventing NICU admission for late preterm and term infants with mild to moderate respiratory distress.", "results_summary": "Early or prophylactic CPAP showed promise in reducing NICU admissions, particularly in cesarean-born infants, though the lack of safety and efficacy data precludes broad recommendation. Two randomized trials using prophylactic CPAP reported significant decreases in NICU admissions, while other interventions (adrenaline, sustained inflation) showed no significant benefit.", "population_specificity": "Late preterm and term infants, with three studies focusing exclusively on cesarean-born infants.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:31.483150+00:00"}
{"study_id": 53903, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of CPAP treatment in reducing stroke recurrence and mortality in patients with moderate to severe sleep-disordered breathing following an ischemic stroke.", "results_summary": "The study found that CPAP treatment in stroke patients with moderate to severe SDB was associated with significantly lower rates of stroke recurrence and death, as evidenced by a reduced odds ratio (0.13) in the treated group.", "population_specificity": "Patients with moderate to severe sleep-disordered breathing (AHI \u2265 15 events/h) after an ischemic stroke, predominantly male (84.1%), average age 68.5 years.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:32.389030+00:00"}
{"study_id": 53901, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare the effectiveness of a spontaneous breathing trial using Continuous Positive Airway Pressure (CPAP) versus physician-led weaning in predicting extubation success in pediatric patients post-cardiac surgery.", "results_summary": "The study found that pediatric patients undergoing the spontaneous breathing trial with CPAP had significantly higher extubation success rates (83% vs. 68%) and shorter PICU stays compared to the control group. No significant differences were observed in hospital length of stay, ventilator-associated pneumonia rates, or mortality.", "population_specificity": "Pediatric patients (median age 8 months) recovering from cardiac surgery for congenital heart disease.", "effective_dosage": "CPAP with pressure support of 10 cmH2O, positive end-expiratory pressure of 5 cmH2O, and FiO2 \u2264 0.5.", "study_duration": "2 hours for the spontaneous breathing trial.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:32.654344+00:00"}
{"study_id": 53904, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the role of Continuous Positive Airway Pressure (CPAP) as the gold standard treatment for Obstructive Sleep Apnea (OSA) and compare it with surgical alternatives.", "results_summary": "CPAP is identified as the gold standard treatment for OSA, but surgical options are considered for patients non-compliant or unwilling to use CPAP. Intrapharyngeal surgery is widely used but may require adjunct therapies for sustained outcomes.", "population_specificity": "Adults with Obstructive Sleep Apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:32.724178+00:00"}
{"study_id": 53907, "supplement_id": 1048, "safety_score": "85", "efficacy_score": 90, "quality_score": 92, "study_goal": "The researchers aimed to compare the efficacy and safety of nasal high-flow therapy versus CPAP as early respiratory support for newborn infants with respiratory distress in nontertiary special care nurseries.", "results_summary": "CPAP was significantly more effective than high-flow therapy, with a lower incidence of treatment failure (10.2% vs. 20.5%). Adverse events and other secondary outcomes did not differ significantly between the groups.", "population_specificity": "Newborn infants (<24 hours of age; gestational age \u226531 weeks; birth weight \u22651200 g) with respiratory distress in nontertiary special care nurseries.", "effective_dosage": "Not specified", "study_duration": "72 hours after randomization", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:37.017222+00:00"}
{"study_id": 53906, "supplement_id": 1048, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the safety and efficacy of Continuous Positive Airway Pressure (CPAP) and non-invasive ventilation (NIV) in treating obesity-related respiratory failure, including severe obstructive sleep apnoea (OSA) and nocturnal hypoventilation.", "results_summary": "The study found that CPAP and NIV are safe and effective for improving respiratory failure, health-related quality of life, and reducing healthcare utilization and mortality in patients with obesity-related respiratory failure and OSA, with or without COPD. However, there is insufficient evidence for CPAP in isolated nocturnal hypoventilation, where NIV is recommended.", "population_specificity": "Patients with obesity-related respiratory failure, including severe OSA, isolated nocturnal hypoventilation, and OSA complicating COPD.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:37.194919+00:00"}
{"study_id": 53908, "supplement_id": 1048, "safety_score": "85", "efficacy_score": 70, "quality_score": 90, "study_goal": "The researchers aimed to compare the effects of sham-CPAP versus conservative medical therapy as control arms and assess adherence, retention, and outcomes in obstructive sleep apnea patients.", "results_summary": "No differences were found in blood pressure, quality of life, dropout rates, or adverse events between sham-CPAP and CMT groups. Sham-CPAP showed lower adherence and self-efficacy compared to active-CPAP.", "population_specificity": "Individuals with obstructive sleep apnea.", "effective_dosage": "Not specified", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:37.562263+00:00"}
{"study_id": 53905, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effects of high-flow nasal cannula (HFNC) therapy compared to nasal continuous positive airway pressure (nCPAP) on respiratory physiology in preterm infants.", "results_summary": "HFNC therapy produced clinically significant positive end-expiratory pressure (pEEP) with variability at higher flow rates, particularly in infants weighing <1000 g. Flow, weight, and mouth position were key determinants of the pressures generated.", "population_specificity": "Preterm infants with birth weights ranging from 500-1900 g, divided into three weight groups (<1000 g, 1000-1500 g, >1500 g).", "effective_dosage": "nCPAP at 6 cm H\u2082O; HFNC flows ranged from 2-8 L/min.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:37.794525+00:00"}
{"study_id": 53910, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the relationship between OSA and cognitive impairments and assess the effectiveness of CPAP in improving cognitive performance in OSA patients.", "results_summary": "The study found that OSA is a risk factor for cognitive impairments and that CPAP therapy can improve cognitive performance, with the duration of CPAP use being crucial for therapeutic effects.", "population_specificity": "Patients with obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:39.698618+00:00"}
{"study_id": 53909, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to identify factors, particularly the fraction of inspired oxygen (FiO2), predictive of CPAP failure in preterm infants with respiratory distress syndrome (RDS) within the first 72 hours of life.", "results_summary": "The study found that FiO2 in the second hour of life is a significant predictor of CPAP failure, with a threshold of 0.29 best discriminating outcomes. CPAP failure was associated with a markedly higher risk of complications and mortality.", "population_specificity": "Preterm infants under 30 weeks gestation who received CPAP within the first 15 minutes after birth.", "effective_dosage": "Not specified", "study_duration": "First 72 hours of life", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:40.358838+00:00"}
{"study_id": 53912, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to review factors impacting the success of noninvasive respiratory support, including CPAP, in managing acute respiratory failure.", "results_summary": "The study found that while CPAP and other noninvasive respiratory supports are effective for many patients, some experience failure due to factors like patient-ventilator synchrony and tolerance issues. Tailoring interventions to individual needs can improve outcomes.", "population_specificity": "Patients with acute respiratory failure receiving noninvasive respiratory support.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:40.427488+00:00"}
{"study_id": 53911, "supplement_id": 1048, "safety_score": "75", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the clinical application, safety, and effectiveness of Continuous Positive Airway Pressure (CPAP) across various care settings and device types.", "results_summary": "The study found that CPAP is widely used for treating acute and chronic conditions, but device performance and safety features vary, impacting therapeutic effectiveness. Proper device selection is crucial to avoid suboptimal pressure and oxygen delivery, which can lead to adverse outcomes.", "population_specificity": "Patients across pre-hospital, acute care, critical care, and home care settings.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:40.932120+00:00"}
{"study_id": 53913, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to assess the effect of CPAP on blood pressure, specifically considering the circadian BP pattern in untreated hypertensive patients.", "results_summary": "The abstract indicates CPAP has a heterogeneous effect on blood pressure in hypertensive patients, but the study did not explore the circadian BP pattern's role in this effect.", "population_specificity": "Untreated hypertensive patients", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:43.881213+00:00"}
{"study_id": 53916, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether CPAP treatment improves nightmare and overall PTSD symptoms in patients with both PTSD and obstructive sleep apnea (OSA).", "results_summary": "The meta-analysis found that CPAP significantly improved nightmare and overall PTSD symptoms in patients with PTSD and OSA, with standardized mean differences indicating moderate to large effects. Improvements in overall PTSD symptoms were linked to CPAP adherence, though subgroup analysis by treatment duration (3 and 6 months) did not reach statistical significance.", "population_specificity": "Patients with PTSD and obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Varied (3 and 6 months subgroups)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:46.360194+00:00"}
{"study_id": 53917, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of Continuous Positive Airway Pressure (CPAP) on erectile function and systemic testosterone exposure in men with obstructive sleep apnea.", "results_summary": "CPAP therapy improved erectile function and possibly systemic testosterone exposure, but only when used adherently by men with obstructive sleep apnea. The study also noted that high-dose and replacement-dose testosterone therapies modestly worsened sleep-disordered breathing but improved cardiometabolic function and sexual desire.", "population_specificity": "Men with obstructive sleep apnea.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:46.893730+00:00"}
{"study_id": 53915, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether a thermoplastic heat-moulded titratable MAD was non-inferior to a custom-made acrylic MAD for treating obstructive sleep apnoea (OSA) in patients refusing or not tolerating CPAP.", "results_summary": "The study found that the thermoplastic heat-moulded titratable MAD was non-inferior to the custom-made acrylic MAD in achieving a \u226550% reduction in AHI or AHI <10 events/hour at 2 months. The non-inferiority margin was set at a 20% difference between groups.", "population_specificity": "Patients with OSA who refused or did not tolerate CPAP (mean age 51 years, 72.6% men, mean BMI 26 kg/m\u00b2).", "effective_dosage": "Not specified", "study_duration": "2 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:47.239570+00:00"}
{"study_id": 53921, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore how understanding OSA endotypes and phenotypes could improve individualized treatment decisions, including the use of Continuous Positive Airway Pressure (CPAP).", "results_summary": "The study highlights that CPAP reliably reduces the AHI but notes low adherence and variable responses to other therapies. It suggests that a deeper understanding of OSA pathogenesis could lead to more personalized treatments and better outcomes.", "population_specificity": "Individuals with obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:48.573269+00:00"}
{"study_id": 53918, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the efficacy of positional therapy versus CPAP and positional therapy versus inactive control in treating obstructive sleep apnoea (OSA).", "results_summary": "CPAP showed a greater reduction in Apnoea-Hypopnoea Index (AHI) compared to positional therapy, but positional therapy had better adherence. Positional therapy improved ESS scores and AHI more than inactive control, with no significant differences in quality of life or cognitive function.", "population_specificity": "People with obstructive sleep apnoea (OSA).", "effective_dosage": "Not specified", "study_duration": "Short-term (specific duration not mentioned)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:48.634345+00:00"}
{"study_id": 53920, "supplement_id": 1048, "safety_score": "85", "efficacy_score": 90, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effectiveness of Continuous Positive Airway Pressure (CPAP) in treating Negative Pressure Pulmonary Edema (NPPE) following anesthetic extubation.", "results_summary": "CPAP, combined with furosemide, effectively stabilized the patient's respiratory distress and resolved pulmonary edema within two days, leading to full recovery and discharge.", "population_specificity": "A 25-year-old woman post-endoscopic thyroidectomy who developed NPPE after extubation.", "effective_dosage": "CPAP (specific settings not detailed) and furosemide 20 mg intravenously.", "study_duration": "Intervention lasted until postoperative day 2.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:49.237177+00:00"}
{"study_id": 53919, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the incidence and risk factors of CPAP failure after minimally invasive surfactant therapy (MIST) in preterm infants with respiratory distress syndrome.", "results_summary": "30% of infants failed CPAP after MIST, with risk factors including gestational age <28 weeks, elevated C-reactive protein, absence of antenatal corticosteroids, and lower surfactant dose. MIST failure was associated with increased risk of severe intraventricular hemorrhage.", "population_specificity": "Preterm infants born between 24 and 31 weeks' gestational age with respiratory distress syndrome.", "effective_dosage": "Poractant alfa (100-200 mg/kg)", "study_duration": "First 72 hours of life", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:49.517019+00:00"}
{"study_id": 53922, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effectiveness of early CPAP and NIV strategies in reducing bronchopulmonary dysplasia (BPD) and mortality in preterm infants with respiratory distress syndrome (RDS).", "results_summary": "Early CPAP reduces the need for invasive mechanical ventilation and the risk of BPD or death in preterm infants with RDS. NIPPV may lower intubation rates compared to CPAP but does not significantly affect BPD rates.", "population_specificity": "Preterm infants with respiratory distress syndrome (RDS).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:52.073096+00:00"}
{"study_id": 53924, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to determine if the endogenous surfactant pool in preterm neonates with RDS is associated with CPAP failure and to identify clinical factors affecting the surfactant pool.", "results_summary": "The study found that gestational age was the only factor significantly associated with lamellar body count (a measure of surfactant pool), and while lamellar body count was higher in neonates with CPAP success, it was not independently associated with CPAP failure after adjusting for confounders. The reliability of lamellar body count to predict CPAP failure was moderate.", "population_specificity": "Preterm neonates with RDS treated with CPAP.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:55.582825+00:00"}
{"study_id": 53923, "supplement_id": 1048, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to determine whether applying CPAP at +5 cm H2O during thoracentesis mitigates decreases in pleural pressure (Ppl) and improves procedural outcomes.", "results_summary": "CPAP at +5 cm H2O significantly increased pleural compliance, preventing Ppl from dropping below -20 cm H2O in all treated patients, unlike controls. No cases of re-expansion pulmonary edema occurred in either group.", "population_specificity": "49 consecutive adults undergoing thoracentesis.", "effective_dosage": "CPAP at +5 cm H2O.", "study_duration": "Duration of the thoracentesis procedure.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:55.915971+00:00"}
{"study_id": 53925, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to update European guidelines for managing respiratory distress syndrome (RDS), including the role of Continuous Positive Airway Pressure (CPAP) in lung protection and non-invasive respiratory support.", "results_summary": "The study found that CPAP, when initiated immediately after birth, is effective in lung protection and reducing the need for mechanical ventilation, potentially lowering the risk of chronic lung disease. Non-invasive respiratory support methods, including CPAP, were noted to cause less distress and improve outcomes.", "population_specificity": "Preterm infants with or at risk of respiratory distress syndrome (RDS).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:56.107680+00:00"}
{"study_id": 53931, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 40, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the relationship between obstructive sleep apnea (OSA) treatment (including Continuous Positive Airway Pressure) and blood pressure control, as well as the comparative efficacy of antihypertensive drugs.", "results_summary": "The study found that OSA treatment has a modest effect on blood pressure, while antihypertensive drugs showed better BP reduction and compliance. Compliance with OSA treatment was often sub-optimal, complicating interpretation of results.", "population_specificity": "Patients with obstructive sleep apnea and hypertension.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:58.310698+00:00"}
{"study_id": 53929, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the feasibility and effectiveness of bubble continuous positive airway pressure (bCPAP) in treating critically ill children with respiratory failure in a low-resource setting.", "results_summary": "Overall survival with bCPAP was 68%, with higher survival (87%) in children with very severe pneumonia without multiorgan failure. Survival rates were lower in children with multiorgan failure (45%), severe malnutrition (36%), and HIV infection/exposure (45%).", "population_specificity": "Critically ill children up to 59 months old with severe respiratory dysfunction in Lilongwe, Malawi.", "effective_dosage": "Not specified", "study_duration": "Treatment duration not explicitly stated; follow-up was 48 hours post-weaning.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:58.311496+00:00"}
{"study_id": 53927, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to identify predictive factors for 12-month and 10-year adherence to Continuous Positive Airway Pressure (CPAP) in patients with Obstructive Sleep Apnoea (OSA).", "results_summary": "The study found that patients with good adherence (\u22654.5 hours nightly use) were more likely to continue CPAP long-term, with nasal mask use associated with better adherence. Dropouts were more common in the poor adherence group and occurred mainly within the first five years.", "population_specificity": "147 patients with OSA who started CPAP between 2006 and 2009.", "effective_dosage": "Not specified (adherence measured by nightly use \u22654.5 hours vs. <4.5 hours).", "study_duration": "10-year follow-up.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:58.639096+00:00"}
{"study_id": 53930, "supplement_id": 1048, "safety_score": "85", "efficacy_score": 80, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the safety and effectiveness of Non-invasive Positive Pressure Ventilation (NPPV), including Continuous Positive Airway Pressure (CPAP), compared to standard medical care for adults with acute cardiogenic pulmonary oedema (ACPE).", "results_summary": "NPPV may reduce hospital mortality and intubation rates compared to standard medical care, with similar adverse event rates, suggesting it is a safe and effective intervention for ACPE.", "population_specificity": "Adults (older than 18 years) with respiratory distress due to ACPE, not requiring immediate mechanical ventilation, presenting to Emergency Departments or as inpatients.", "effective_dosage": "Not specified", "study_duration": "Median follow-up of 13 days for hospital mortality, one day for endotracheal intubation, and three days for acute myocardial infarction.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:28:59.372441+00:00"}
{"study_id": 53932, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to compare the effects of auto-adjusting positive airway pressure (APAP) versus fixed CPAP on muscle sympathetic nerve activity (MSNA) in treatment-naive OSA patients.", "results_summary": "No results are presented in the abstract, as the manuscript describes only the study design. The primary outcome will be the change in sympathetic tone measured by MSNA after 30 days of treatment.", "population_specificity": "Adult subjects with newly diagnosed OSA (Apnoea-Hypopnoea Index >20/hour).", "effective_dosage": "Not specified", "study_duration": "30 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:00.310572+00:00"}
{"study_id": 53935, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to determine whether nonpharmacological interventions, specifically CPAP, administered during sleep could enhance physical rehabilitation outcomes in individuals with neurological diagnoses, particularly stroke and sleep apnea.", "results_summary": "The review found mixed results across studies, but several indicated that CPAP use during early stroke recovery had benefits compared to no CPAP, especially in participants with good compliance. The review highlighted limitations such as varied outcome measures and lack of detailed rehabilitation descriptions.", "population_specificity": "Inpatient individuals with stroke and sleep apnea, with some long-term outpatient follow-ups.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:04.409312+00:00"}
{"study_id": 53934, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to compare the clinical effectiveness and safety of a multilevel upper airway surgical procedure versus ongoing medical management (including Continuous Positive Airway Pressure) in patients with moderate or severe OSA who had failed or refused medical therapies.", "results_summary": "The study compared surgical intervention to ongoing medical management, focusing on OSA severity and subjective sleepiness. Results for Continuous Positive Airway Pressure specifically were not detailed in the abstract, but the study noted its poor tolerance in up to 50% of patients.", "population_specificity": "Adults with moderate or severe OSA who had failed or refused medical therapies.", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:04.422791+00:00"}
{"study_id": 53933, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the efficacy of Continuous Positive Airway Pressure (CPAP) in improving nonalcoholic fatty liver disease (NAFLD) in patients with obstructive sleep apnea (OSA) and chronic intermittent hypoxia (CIH).", "results_summary": "Observational studies with longer CPAP therapy durations showed positive outcomes for NAFLD, while shorter-duration randomized controlled trials found no benefit. A multifaceted approach with sufficiently longer CPAP therapy may benefit patients with moderate to severe OSA.", "population_specificity": "Patients with moderate to severe obstructive sleep apnea (OSA) and nonalcoholic fatty liver disease (NAFLD).", "effective_dosage": "Not specified", "study_duration": "Varies (longer durations in observational studies, shorter in RCTs)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:04.949607+00:00"}
{"study_id": 53937, "supplement_id": 1048, "safety_score": "85", "efficacy_score": 75, "quality_score": 90, "study_goal": "The researchers aimed to compare the long-term effectiveness of non-invasive ventilation and continuous positive airway pressure in treating obesity hypoventilation syndrome with severe obstructive sleep apnea.", "results_summary": "The study found no significant difference in hospitalisation days per year between continuous positive airway pressure and non-invasive ventilation, suggesting similar long-term effectiveness. Adverse events were similar between both groups.", "population_specificity": "Patients aged 15-80 years with untreated obesity hypoventilation syndrome and an apnoea-hypopnoea index of 30 or more events per hour.", "effective_dosage": "Not specified", "study_duration": "Median follow-up was 5.44 years (IQR 4.45-6.37)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:07.636553+00:00"}
{"study_id": 53936, "supplement_id": 1048, "safety_score": "80", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the efficacy and tolerance of CPAP with or without heated humidification (ThermoSmart) in severe obstructive sleep apnea (OSA) patients.", "results_summary": "Both CPAP modalities normalized AHI and reduced sleepiness equally, but heated humidification significantly decreased nasal symptoms like dry/congested nose. Most patients preferred ThermoSmart despite no improvement in compliance.", "population_specificity": "Severe OSA patients (AHI 46.7 \u00b1 15.3/hour), CPAP-naive, aged 62 \u00b1 9 years, with risk factors like age >65, drying medication use, or prior nasal issues.", "effective_dosage": "Not specified", "study_duration": "1 month per treatment arm (2 months total)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:08.251247+00:00"}
{"study_id": 53939, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to summarize the role of pneumologists in diagnosing and treating pediatric obstructive Sleep Disordered Breathing (SDB), including the use of CPAP and NIPPV when surgery is contraindicated or ineffective.", "results_summary": "CPAP and NIPPV are recommended for pediatric OSA when adenotonsillectomy is insufficient or contraindicated, though residual symptoms like hypersomnia and apnea may persist. Current understanding of pediatric OSA mechanisms and phenotypic variability remains incomplete.", "population_specificity": "Children with obstructive SDB, particularly those with obesity, craniofacial pathologies, neuromuscular disorders, or adenotonsillar hypertrophy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:08.273675+00:00"}
